{"meta":{"query_hash":"93af81fa94a8","filters":{"venue":"Crohn s & Colitis 360"},"cohort_total":64,"direct_labels_cover":0,"predictions_cover":64,"exported":64,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93af81fa94a8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Crohn+s+%26+Colitis+360"},"results":[{"id":"W2963228128","doi":"10.1093/crocol/otz014","title":"The Impact of Private Insurance Access on Nonurgent Inflammatory Bowel Disease-Related Emergency Department Use","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Emergency department; Quartile; Confidence interval; Inflammatory bowel disease; Odds ratio; Logistic regression; Retrospective cohort study; Emergency medicine; Internal medicine; Disease","score_opus":0.009506544557702737,"score_gpt":0.270527784559207,"score_spread":0.2610212400015043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963228128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967749,0.00048381544,0.000004747507,0.000029349387,0.0005459769,0.0010239794,0.00037051027,0.000025990315,0.00074074604],"genre_scores_gemma":[0.9977314,0.00054207566,0.000005016342,0.0000498554,0.00008989034,0.00012637935,0.00016637903,0.000049434122,0.0012395869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809515,0.00015369685,0.00052949437,0.0004458101,0.0002842195,0.0004916439],"domain_scores_gemma":[0.99810606,0.000024846226,0.000288028,0.0010766889,0.00018563974,0.00031875502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017933217,0.000298823,0.00018132689,0.000047815516,0.00016170635,0.000069303824,0.00054127467,0.00012576411,0.0002253807],"category_scores_gemma":[0.00014343447,0.00023062095,0.00037163627,0.00009812281,0.00013109474,0.000026935553,0.00023853878,0.00012003248,0.00012107577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029154567,0.00020227837,0.9814684,0.00008973147,0.0003073622,0.00014169309,0.00003884284,0.0019804258,0.0069784163,0.0008934879,0.0045518563,0.0004320417],"study_design_scores_gemma":[0.00069449533,0.0001290374,0.9916027,0.000044799035,0.000023674354,0.0000023611624,0.000005828502,0.000101217935,0.0023694448,0.00019457997,0.0045538587,0.00027799106],"about_ca_topic_score_codex":0.00003269858,"about_ca_topic_score_gemma":0.00003061355,"teacher_disagreement_score":0.010134304,"about_ca_system_score_codex":0.000080099664,"about_ca_system_score_gemma":0.00033543707,"threshold_uncertainty_score":0.94044495},"labels":[],"label_agreement":null},{"id":"W2992514761","doi":"10.1093/crocol/otz050","title":"Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Adalimumab; Medicine; Inflammatory bowel disease; Therapeutic drug monitoring; Drug; Inflammatory Bowel Diseases; Internal medicine; Disease; Intensive care medicine; Pharmacology","score_opus":0.0036634431316890895,"score_gpt":0.2047155842064288,"score_spread":0.2010521410747397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992514761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984861,0.00030176662,0.000004587046,0.000009848172,0.00018823973,0.00055116817,0.000050843682,0.000014445536,0.00039297226],"genre_scores_gemma":[0.99922574,0.000017690581,0.00003497701,0.000060947204,0.00008659141,0.000051653147,0.000060429385,0.0000413764,0.00042058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987492,0.00007725734,0.00026828342,0.00034017276,0.00024379,0.00032129136],"domain_scores_gemma":[0.99901175,0.00000963156,0.000118565884,0.0005554823,0.00013957704,0.000164996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095448915,0.00019251106,0.00015245592,0.00006692936,0.000034781962,0.000019600628,0.00021910862,0.000073950105,0.000045175035],"category_scores_gemma":[0.000020037727,0.00018700084,0.00007487797,0.000064297245,0.000090525835,0.000013689242,0.00008965323,0.00008774871,0.0000305304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021725625,0.00012032455,0.99603385,0.00014363362,0.000038143622,0.00004813795,0.000077736506,0.00012313532,0.0007628252,0.000097592274,0.000045629495,0.0003364457],"study_design_scores_gemma":[0.0021498154,0.000068627196,0.99495286,0.00009980979,0.000021556796,3.0790216e-7,0.00006134249,0.000013291671,0.0017356803,0.00004526335,0.0006179015,0.00023356726],"about_ca_topic_score_codex":0.000011578873,"about_ca_topic_score_gemma":0.000020675701,"teacher_disagreement_score":0.001080997,"about_ca_system_score_codex":0.000042619533,"about_ca_system_score_gemma":0.00023318875,"threshold_uncertainty_score":0.7625673},"labels":[],"label_agreement":null},{"id":"W2995687733","doi":"10.1093/crocol/otz053","title":"Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Adverse effect; Randomized controlled trial; Depression (economics); Anxiety; Psychosis; Inflammatory bowel disease; Psychiatry; Cohort; Internal medicine; Confidence interval; Disease; Pediatrics","score_opus":0.024588527450321664,"score_gpt":0.31735018825095423,"score_spread":0.2927616608006326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995687733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008716186,0.97765625,0.000003139289,0.000017482254,0.00017484256,0.012977559,0.00030295333,0.000046386762,0.000105176885],"genre_scores_gemma":[0.0011336091,0.9955863,0.00013233365,0.000046182242,0.00008303775,0.0015051198,0.00010285463,0.000081031656,0.0013295766],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99595416,0.0004110579,0.0020276313,0.0006680702,0.0004823061,0.00045675944],"domain_scores_gemma":[0.9954367,0.0001963452,0.002041632,0.0017817239,0.0002502998,0.00029327147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002504565,0.0007251821,0.005390697,0.00034921488,0.00005229623,0.0000049537616,0.0003677153,0.00022149332,0.00023359139],"category_scores_gemma":[0.00017357925,0.00046657858,0.0010453708,0.0004983864,0.0001700552,0.00006788822,0.0000886514,0.00018300788,0.000089530164],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014511486,0.00024925804,0.0019091796,0.9940365,0.0007935688,0.00023105778,0.000105120474,1.2274644e-7,7.387117e-7,0.00003232471,0.000024465653,0.0024725331],"study_design_scores_gemma":[0.0013663569,0.00072466565,0.016224917,0.94556046,0.013757117,0.0002808082,0.00003011556,4.938896e-7,0.000001369546,0.00000918206,0.021634797,0.00040974468],"about_ca_topic_score_codex":0.00007178994,"about_ca_topic_score_gemma":0.000019405086,"teacher_disagreement_score":0.04847608,"about_ca_system_score_codex":0.0006554583,"about_ca_system_score_gemma":0.0017879518,"threshold_uncertainty_score":0.99977857},"labels":[],"label_agreement":null},{"id":"W3006447266","doi":"10.1093/crocol/otaa008","title":"Oral Bran in Patients With Quiescent Ulcerative Colitis: Another Piece in the Diet Puzzle","year":2020,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Ulcerative colitis; Bran; Medicine; Gastroenterology; Internal medicine; Food science; Dermatology; Biology; Disease","score_opus":0.011140198746264048,"score_gpt":0.27531735513825106,"score_spread":0.264177156391987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006447266","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13126674,0.0044699283,0.00011229315,0.023928732,0.6593135,0.055503845,0.012177223,0.00065987493,0.11256784],"genre_scores_gemma":[0.56596386,0.001398719,0.00011797566,0.0051147533,0.40583605,0.0035096318,0.009058673,0.00044831383,0.008552033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549854,0.00039505647,0.0004929934,0.0007601913,0.0019280979,0.00092512165],"domain_scores_gemma":[0.99838996,0.00022364572,0.0001409273,0.0006263376,0.0003009162,0.00031823624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000408788,0.00046703077,0.0008165701,0.0002524148,0.00010775506,0.00019751218,0.00042703364,0.00029638215,0.0003871623],"category_scores_gemma":[0.0005728082,0.0003379377,0.00014217125,0.00059474685,0.00024743815,0.0001313573,0.00021198118,0.0011606558,0.000100913305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013104787,0.0009677596,0.0048277555,0.0006692567,0.00015804385,0.0010944016,0.0010267771,9.60211e-7,1.2046009e-7,0.00015410963,0.9754265,0.0025695302],"study_design_scores_gemma":[0.0058122566,0.0010997133,0.3649702,0.0006286723,0.000078192425,4.1729888e-7,0.0003393219,0.000004643625,0.0000010906572,0.000037063146,0.62679374,0.00023467529],"about_ca_topic_score_codex":0.0015944424,"about_ca_topic_score_gemma":0.009970019,"teacher_disagreement_score":0.4346971,"about_ca_system_score_codex":0.000672252,"about_ca_system_score_gemma":0.0009065771,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W3020960254","doi":"10.1093/crocol/otaa033","title":"Patient’s Perspective on Disease Burden, Remission Definition, and Symptoms Associated With Treatment Seeking: A Qualitative Study in Adult and Adolescent Patients With Crohn’s Disease","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Abdominal pain; Disease; Diarrhea; Thematic analysis; Internal medicine; Population; Young adult; Crohn's disease; Qualitative research; Physical therapy; Pediatrics","score_opus":0.011616517622785563,"score_gpt":0.25374612539727054,"score_spread":0.24212960777448497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020960254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972638,0.00013999407,0.000008024306,0.00025594613,0.00001791023,0.0016580459,0.0005113172,0.000027136914,0.00011781355],"genre_scores_gemma":[0.9986423,0.000023300749,0.0000140200655,0.0006036383,0.000044627646,0.00026285416,0.00033423552,0.00004489301,0.000030088957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979732,0.00037270688,0.00024588036,0.00078104547,0.0003090791,0.00031810065],"domain_scores_gemma":[0.9984581,0.000029287052,0.00015358244,0.00025144636,0.0003922737,0.00071530335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005374022,0.00034951858,0.00023892775,0.000056737408,0.00016413421,0.00006610388,0.00006673006,0.00006384435,0.00000772923],"category_scores_gemma":[0.00033312856,0.00028191248,0.00004385403,0.00011886629,0.0001735839,0.000016593382,0.00007592097,0.00010004868,0.0000022956613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049253672,0.0036683467,0.90487355,0.00013451184,0.00036737765,0.0028583915,0.03737876,0.0000556303,0.000047239384,0.0003295387,0.00024030804,0.0007926834],"study_design_scores_gemma":[0.0068082684,0.0028135711,0.9785373,0.00029683212,0.00015642827,5.353378e-7,0.010815005,0.00005566025,0.000019830053,0.000064173895,0.000050780644,0.00038156757],"about_ca_topic_score_codex":0.000047842612,"about_ca_topic_score_gemma":0.00016442437,"teacher_disagreement_score":0.0736638,"about_ca_system_score_codex":0.0002437071,"about_ca_system_score_gemma":0.00025270582,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W3033809361","doi":"10.1093/crocol/otaa048","title":"Inflammatory Bowel Disease and the Environment: More to Come","year":2020,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Medicine; Internal medicine","score_opus":0.003747573963178033,"score_gpt":0.21484921195287607,"score_spread":0.21110163798969803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033809361","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33125713,0.0109168645,0.00017166889,0.004001339,0.6326466,0.0072280546,0.010633746,0.00022598318,0.0029185947],"genre_scores_gemma":[0.073686816,0.0016228781,0.0000890796,0.00348156,0.9088282,0.0014315702,0.0041081836,0.00035784312,0.006393844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973383,0.00022189762,0.00042706652,0.0009113493,0.00059308455,0.00050830195],"domain_scores_gemma":[0.9977447,0.00008613307,0.0001823472,0.0010352107,0.00009425107,0.0008573949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024414915,0.0005319628,0.0003694561,0.00004889805,0.00024883178,0.00016194553,0.00064914214,0.0005383398,0.00008105471],"category_scores_gemma":[0.0007972016,0.00046725397,0.00025200978,0.000041091884,0.00067971874,0.000006614487,0.0008649978,0.00044537458,0.0002003822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034292,0.000026984353,0.0005191838,0.0002998461,0.00017247406,0.0008379448,0.00015501655,0.000026081078,0.00013666427,0.00019407977,0.99402314,0.00017939774],"study_design_scores_gemma":[0.0017706286,0.000044467364,0.06978681,0.000058749807,0.00020502304,0.0000015855826,0.000032479802,0.000017370186,0.000043267286,0.00011030338,0.9273957,0.00053360395],"about_ca_topic_score_codex":0.000013594461,"about_ca_topic_score_gemma":0.000018408065,"teacher_disagreement_score":0.2761816,"about_ca_system_score_codex":0.00006549197,"about_ca_system_score_gemma":0.0005413156,"threshold_uncertainty_score":0.9997779},"labels":[],"label_agreement":null},{"id":"W3033916598","doi":"10.1093/crocol/otaa044","title":"Changing Patterns of Relationships Between Geographic Markers and IBD: Possible Intrusion of Obesity","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Obesity; Population; Vitamin D and neurology; Demography; Inflammatory bowel disease; Incidence (geometry); Latitude; Medicine; Disease; Epidemiology; Geography; Environmental health; Internal medicine","score_opus":0.019039540524481906,"score_gpt":0.24518161605397,"score_spread":0.2261420755294881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033916598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972993,0.0007772635,0.0005475641,0.00015295256,0.000046944824,0.00021019204,0.0001009218,0.00000804126,0.0008567967],"genre_scores_gemma":[0.99927783,0.00030826658,0.00008422313,0.000047827383,0.00009108817,0.0000043140544,0.0000843838,0.000011270191,0.00009077387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915105,0.000112012436,0.00025761029,0.0002069436,0.00009187741,0.00018052064],"domain_scores_gemma":[0.99949175,0.000023922594,0.00014529916,0.00013195246,0.000080365935,0.00012672419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023397707,0.00009197461,0.0001923567,0.00007037938,0.000096295174,0.000006968011,0.00007913684,0.00016972453,0.000011872792],"category_scores_gemma":[0.000065839224,0.000089507215,0.000056745168,0.0001480621,0.000075379314,0.000004270047,0.000102541286,0.00010539565,0.0000015206216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007405782,0.000019143934,0.9927535,0.00035702964,0.00005750061,0.000003437565,0.00042301544,0.0000037773236,0.0045018177,0.00027662815,0.00006350194,0.0014666017],"study_design_scores_gemma":[0.00033937368,0.0002234356,0.9872744,0.00013769188,0.00003114249,0.0000034955776,0.00044040335,0.000012669713,0.010628122,0.00005804641,0.00075794634,0.00009329305],"about_ca_topic_score_codex":0.00009548243,"about_ca_topic_score_gemma":0.000019037028,"teacher_disagreement_score":0.006126304,"about_ca_system_score_codex":0.00000535859,"about_ca_system_score_gemma":0.00005213339,"threshold_uncertainty_score":0.36499983},"labels":[],"label_agreement":null},{"id":"W3034504576","doi":"10.1093/crocol/otaa049","title":"Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Kyowa Kirin Pharmaceutical Development","keywords":"Medicine; Placebo; Ulcerative colitis; Gastroenterology; Clinical endpoint; Internal medicine; Adverse effect; Pharmacodynamics; Ascending colon; Phases of clinical research; Monoclonal antibody; Population; Randomized controlled trial; Pharmacokinetics; Clinical trial; Surgery; Antibody; Immunology; Pathology; Disease","score_opus":0.02534543814436496,"score_gpt":0.32525069056117656,"score_spread":0.2999052524168116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034504576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958379,0.00008692882,0.00026329374,0.00006652839,0.00012325951,0.0020343265,0.0003936841,0.000029580784,0.0011644532],"genre_scores_gemma":[0.9985465,0.00006312213,0.00012992663,0.00028104967,0.00027246014,0.00019912943,0.00039101843,0.000054450047,0.00006236627],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99686646,0.0008484142,0.0006966058,0.0007805242,0.0003022654,0.00050569803],"domain_scores_gemma":[0.99864143,0.00005148516,0.00027299387,0.00040349065,0.00027186636,0.00035873274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036845592,0.00037392616,0.0007813694,0.00010749011,0.00014631255,0.000078538316,0.00033250081,0.0001859079,0.000110469045],"category_scores_gemma":[0.00026918133,0.00040036367,0.00019659588,0.00021002334,0.000268783,0.00004344916,0.00018582368,0.00022164264,0.00001086607],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88510084,0.0055782665,0.008188548,0.00027092316,0.0010930104,0.004640646,0.012734901,0.0017120139,0.07369649,0.0024073957,0.00053436036,0.004042593],"study_design_scores_gemma":[0.3140513,0.0016737789,0.630502,0.000073403855,0.0001935431,0.000025969985,0.0044806204,0.0059987623,0.041533004,0.00018682556,0.0003510763,0.0009297183],"about_ca_topic_score_codex":0.00021902133,"about_ca_topic_score_gemma":0.000409218,"teacher_disagreement_score":0.62231344,"about_ca_system_score_codex":0.00005066661,"about_ca_system_score_gemma":0.00034306396,"threshold_uncertainty_score":0.99984485},"labels":[],"label_agreement":null},{"id":"W3047137954","doi":"10.1093/crocol/otaa063","title":"Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Janssen Research and Development; Janssen Biotech; Hospital for Sick Children; Danone; Genentech; Mead Johnson Nutrition; AstraZeneca; Celgene; Biogen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Golimumab; Ulcerative colitis; Interquartile range; Internal medicine; Incidence (geometry); Gastroenterology; Surgery; Pharmacokinetics; Infliximab","score_opus":0.012066425721150121,"score_gpt":0.24250840528059572,"score_spread":0.2304419795594456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047137954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607354,0.000046220615,0.00003159106,0.00014352708,0.000086089436,0.0020566802,0.0005125828,0.00003073354,0.0010190175],"genre_scores_gemma":[0.99810743,0.000040018214,0.00006023417,0.00044639705,0.00021195316,0.0003563013,0.00027153234,0.000055863853,0.0004502757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977592,0.00013563408,0.00037558007,0.0008615278,0.00030012964,0.00056788826],"domain_scores_gemma":[0.99872243,0.000013981438,0.00013542263,0.00048211837,0.0002356097,0.0004104206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007294516,0.0003649299,0.0002875965,0.00007194952,0.000103141516,0.00008181275,0.00030899726,0.0001202719,0.000018695306],"category_scores_gemma":[0.00010388453,0.00033072292,0.00008140019,0.00022275787,0.000045998902,0.000019917517,0.00018227035,0.000111197325,0.00007047301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13206282,0.003604977,0.844235,0.00014662063,0.000350356,0.0047977534,0.005722196,0.0010327167,0.00015004507,0.000029080697,0.0020890268,0.0057793916],"study_design_scores_gemma":[0.007122035,0.0022945139,0.9889926,0.00001621541,0.000077654266,0.0000029205114,0.0001662426,0.000020758049,0.00047541983,0.000004300316,0.00042333864,0.00040400896],"about_ca_topic_score_codex":0.00007487925,"about_ca_topic_score_gemma":0.0011263237,"teacher_disagreement_score":0.14475757,"about_ca_system_score_codex":0.00019669463,"about_ca_system_score_gemma":0.00035662344,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W3049275833","doi":"10.1093/crocol/otaa067","title":"Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Fecal bacteriotherapy; Ulcerative colitis; Feces; Transplantation; Medicine; Colitis; Internal medicine; Gastroenterology; Microbiology; Biology; Clostridium difficile; Disease; Antibiotics","score_opus":0.05053767165795414,"score_gpt":0.3251094836251865,"score_spread":0.27457181196723235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049275833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024403,0.00060169515,0.00073250214,0.0034022923,0.00013309151,0.0019617802,0.00062523986,0.00015546482,0.0021439048],"genre_scores_gemma":[0.9944022,0.0007253335,0.00061151566,0.0018653201,0.00097122305,0.0002163672,0.0005978295,0.00006759437,0.000542577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979597,0.000105618274,0.00038296307,0.0005869137,0.00033599368,0.0006288194],"domain_scores_gemma":[0.9985159,0.00015789832,0.00006696725,0.000273355,0.0004507121,0.00053513737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017864547,0.0002666683,0.00044077064,0.00009003588,0.00026683626,0.00015562287,0.0001786176,0.00018040802,0.0007046553],"category_scores_gemma":[0.00013819298,0.00026230377,0.00020330223,0.00030558262,0.00014023783,0.00019894323,0.000024115068,0.00030548536,0.00007180041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048848134,0.0015670466,0.002148992,0.0020155862,0.0006883846,0.0015029814,0.016993526,0.000026047312,0.76371175,0.0027433885,0.04261857,0.11713561],"study_design_scores_gemma":[0.01635008,0.0058850236,0.3124755,0.00034653404,0.00026197254,0.00035198763,0.0020348115,0.003550585,0.58867645,0.00014677724,0.06899997,0.0009203117],"about_ca_topic_score_codex":0.00016322552,"about_ca_topic_score_gemma":0.00011909278,"teacher_disagreement_score":0.31032652,"about_ca_system_score_codex":0.00016454978,"about_ca_system_score_gemma":0.00043871565,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W3093973890","doi":"10.1093/crocol/otaa085","title":"Patients’ Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Disease; Thematic analysis; Inflammatory bowel disease; Clinical trial; Family medicine; Immunology; Internal medicine; Qualitative research","score_opus":0.010673969021678109,"score_gpt":0.21671177871409625,"score_spread":0.20603780969241814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093973890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322283,0.004651179,0.00014551794,0.00017259542,0.00017896711,0.00096744846,0.00044316056,0.000058586953,0.00015973423],"genre_scores_gemma":[0.9967835,0.0009132227,0.00019995014,0.0007091401,0.0007240479,0.00018927337,0.0002859017,0.00007455889,0.00012039405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843645,0.000082518265,0.000266561,0.0006500762,0.0001728446,0.00039155575],"domain_scores_gemma":[0.998905,0.000017443455,0.00013586525,0.00031123232,0.00023709306,0.00039334228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006237479,0.00030170075,0.00021869077,0.00003025373,0.0001977597,0.00007087293,0.00022938236,0.00014514886,0.00006348821],"category_scores_gemma":[0.00009560014,0.00031501523,0.00017677284,0.00005837991,0.000264335,0.000019490713,0.000113543225,0.00007503332,0.000015105402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01015165,0.0008631791,0.8687481,0.0010343336,0.00045855367,0.000083320745,0.0065107094,0.00006201373,0.0733446,0.00071053236,0.026383158,0.01164985],"study_design_scores_gemma":[0.0020831914,0.00028340102,0.94749075,0.000014473022,0.000028991612,6.452199e-7,0.00051171874,0.000040232757,0.009402835,0.000041940842,0.03966446,0.00043738817],"about_ca_topic_score_codex":0.0000033968545,"about_ca_topic_score_gemma":0.000001864322,"teacher_disagreement_score":0.07874262,"about_ca_system_score_codex":0.000026630021,"about_ca_system_score_gemma":0.00021306434,"threshold_uncertainty_score":0.9999302},"labels":[],"label_agreement":null},{"id":"W3104299710","doi":"10.1093/crocol/otaa084","title":"Impact of Diet on Inflammatory Bowel Disease Symptoms: An Adolescent Viewpoint","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cleveland Clinic","keywords":"Medicine; Inflammatory bowel disease; Odds ratio; Disease; Confidence interval; Internal medicine; Cross-sectional study; Crohn's disease; Physical therapy; Pathology","score_opus":0.019570834938181014,"score_gpt":0.3024873498485253,"score_spread":0.2829165149103443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104299710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537396,0.0006182954,0.00003066077,0.0012623817,0.00014481114,0.0009868067,0.00028357495,0.00013763394,0.0011618566],"genre_scores_gemma":[0.99578714,0.00011139172,0.00004852401,0.0031987354,0.00048891956,0.00004772409,0.00007983582,0.00005702704,0.00018068138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997986,0.00009507006,0.00052735786,0.0004955134,0.00040355558,0.00049250503],"domain_scores_gemma":[0.99758875,0.00003831393,0.00015637132,0.0007094113,0.00016921858,0.0013379306],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010058087,0.00029989702,0.0005115781,0.00009282652,0.000063486106,0.000031479245,0.00020428217,0.00010022379,0.0012279226],"category_scores_gemma":[0.00025202948,0.00027672862,0.00033616388,0.00016782964,0.00018203793,0.0001081356,0.00010933553,0.0002960074,0.00016422426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030356983,0.0029265368,0.8690435,0.0054134578,0.00062956364,0.0040523987,0.0047742273,0.0000788494,0.010544685,0.0038370641,0.04604665,0.022296032],"study_design_scores_gemma":[0.0019240936,0.0023583567,0.9871921,0.000761998,0.000119024844,0.000013499709,0.00004360844,0.0002219631,0.0006191681,0.00007690533,0.006433444,0.00023583128],"about_ca_topic_score_codex":0.00014161222,"about_ca_topic_score_gemma":0.000022275393,"teacher_disagreement_score":0.11814855,"about_ca_system_score_codex":0.0003233573,"about_ca_system_score_gemma":0.0006877069,"threshold_uncertainty_score":0.99996847},"labels":[],"label_agreement":null},{"id":"W3112937045","doi":"10.1093/crocol/otaa080","title":"Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Crohn's and Colitis Canada","keywords":"Emergency department; Medicine; Inflammatory bowel disease; Incidence (geometry); Care pathway; Managed care; Emergency medicine; Rate ratio; Disease; Disease management; Intensive care medicine; Internal medicine; Health care; Confidence interval","score_opus":0.03630287731488946,"score_gpt":0.30457934057622793,"score_spread":0.26827646326133847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112937045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901936,0.0039874613,0.000039728147,0.00026749674,0.0004011935,0.00094183977,0.0002153271,0.00006740398,0.003885942],"genre_scores_gemma":[0.9951175,0.0038098835,0.0001594262,0.00020732463,0.00014891147,0.00009120111,0.00035740226,0.000024967921,0.0000833994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983945,0.000050290648,0.00057610136,0.00036315265,0.00038407557,0.00023188531],"domain_scores_gemma":[0.99886435,0.00001049804,0.00016201829,0.0002424637,0.00040652914,0.00031411173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005432642,0.00018487958,0.00029164646,0.000031419862,0.00010322445,0.0000047472945,0.00009663166,0.000046942765,0.00019528579],"category_scores_gemma":[0.00005285447,0.00015413183,0.00014225947,0.00016327562,0.000107397704,0.000074950054,0.00010490874,0.00009185836,0.000016666741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018460411,0.0004923142,0.9646228,0.0019324019,0.0004884255,0.00033673167,0.0017076563,0.0000059303707,0.000004768715,0.0009990009,0.011467283,0.016096665],"study_design_scores_gemma":[0.0013945325,0.0005436822,0.98109293,0.0002639741,0.00040138199,2.2004292e-7,0.0014892297,0.000011447972,0.00011434912,0.00003102951,0.014496379,0.00016082093],"about_ca_topic_score_codex":0.0000032530627,"about_ca_topic_score_gemma":0.0000057841244,"teacher_disagreement_score":0.016470172,"about_ca_system_score_codex":0.00003753468,"about_ca_system_score_gemma":0.0000821657,"threshold_uncertainty_score":0.62853134},"labels":[],"label_agreement":null},{"id":"W3136373647","doi":"10.1093/crocol/otaa094","title":"The Genetics of Postoperative Recurrence in Crohn Disease: A Systematic Review, Meta-analysis, and Framework for Future Work","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Health Services","keywords":"Medicine; Odds ratio; Meta-analysis; Crohn's disease; Odds; Disease; NOD2; Genotype; Internal medicine; Surgery; Logistic regression; Genetics; Biology; Gene","score_opus":0.02224698654854236,"score_gpt":0.2857195583987892,"score_spread":0.26347257185024686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136373647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1884819,0.7955865,0.00415687,0.005058183,0.00014515365,0.0055268453,0.0009737818,0.000016726612,0.000054010536],"genre_scores_gemma":[0.97532433,0.016318148,0.0018629532,0.004614871,0.0001815535,0.0013680252,0.00015541245,0.00003730129,0.00013739971],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9983386,0.00031262112,0.000537232,0.0003978981,0.00017176416,0.00024193346],"domain_scores_gemma":[0.99866086,0.000105442756,0.00024072158,0.0005532083,0.00023455553,0.00020523675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000326103,0.00021036064,0.0007010934,0.000027194184,0.00011009523,0.000050869832,0.0003018402,0.00010280824,0.000020260266],"category_scores_gemma":[0.00095326063,0.00014915991,0.0005103673,0.000337397,0.00014463592,0.0000046566674,0.00010971279,0.00010889641,0.0000022896613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01688785,0.00095979334,0.047786735,0.6089953,0.21648252,0.0022682743,0.0071798833,0.0007551531,0.0012559998,0.058479384,0.035781037,0.0031680523],"study_design_scores_gemma":[0.0011512736,0.000294263,0.81149197,0.006355564,0.1647821,0.00000715033,0.0008523905,0.00036093112,0.0010368086,0.0019383469,0.010291652,0.0014375285],"about_ca_topic_score_codex":0.0000015131059,"about_ca_topic_score_gemma":0.000041296862,"teacher_disagreement_score":0.78684247,"about_ca_system_score_codex":0.000010913449,"about_ca_system_score_gemma":0.00013479033,"threshold_uncertainty_score":0.60825646},"labels":[],"label_agreement":null},{"id":"W3160713624","doi":"10.1093/crocol/otab019","title":"Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Trough (economics); Crohn's disease; Medicine; Antibody; Single Center; Trough level; Disease; Immunology; Internal medicine","score_opus":0.020555024919639,"score_gpt":0.26614000881554034,"score_spread":0.24558498389590133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160713624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956467,0.0018840503,0.000053869277,0.00013787439,0.00016886482,0.00022012631,0.00019205459,0.000019312747,0.0016771506],"genre_scores_gemma":[0.9976578,0.00011892542,0.0001743602,0.00044472964,0.00014893418,0.000080705286,0.00009865989,0.000029402545,0.0012465257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985104,0.000102118196,0.00025797109,0.0005545268,0.00014844546,0.00042653637],"domain_scores_gemma":[0.9991471,0.000011405127,0.000054761873,0.00043604753,0.000116818424,0.00023387841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039720813,0.00021008633,0.00017921333,0.00004091744,0.00010659393,0.00010736461,0.00014478609,0.000103734266,0.000121812],"category_scores_gemma":[0.0001760771,0.00023645362,0.00008492953,0.00008889853,0.0002314659,0.000017076243,0.00023959453,0.00007752394,0.0000126181085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003982192,0.0014090696,0.78311765,0.000658826,0.00015774474,0.059180897,0.0029654293,0.000021844131,0.13064587,0.0022820695,0.004994208,0.010584173],"study_design_scores_gemma":[0.0011568092,0.0000210596,0.971925,0.00007507524,0.000012687658,0.000106176376,0.00023300252,0.000018634431,0.0078109545,0.00013749218,0.018207101,0.00029599664],"about_ca_topic_score_codex":0.000013809076,"about_ca_topic_score_gemma":0.00021950439,"teacher_disagreement_score":0.18880734,"about_ca_system_score_codex":0.00004034902,"about_ca_system_score_gemma":0.00022311613,"threshold_uncertainty_score":0.9642299},"labels":[],"label_agreement":null},{"id":"W3166200201","doi":"10.1093/crocol/otab032","title":"Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Interquartile range; Medicine; Gastroenterology; Quartile; Internal medicine; Crohn's disease; Receiver operating characteristic; Area under the curve; Confidence interval; Crohn disease; Ustekinumab; Surgery; Disease; Adalimumab","score_opus":0.007901095325530263,"score_gpt":0.23041292508573527,"score_spread":0.222511829760205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166200201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968863,0.00062393316,0.00033556894,0.00036671312,0.000111936446,0.00044412594,0.00092973944,0.000046429665,0.0002552161],"genre_scores_gemma":[0.9964778,0.00002763924,0.000082180624,0.0010926233,0.000075488606,0.00012481771,0.0012569845,0.00005028846,0.00081221934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979383,0.00026574495,0.0003616199,0.0006060275,0.00026752354,0.0005608331],"domain_scores_gemma":[0.99858063,0.000035591376,0.0001828501,0.0005086568,0.0002783646,0.00041390865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012230154,0.0002771029,0.00024638957,0.000050860297,0.00020446228,0.00010373393,0.00016662499,0.0002071303,0.00013497328],"category_scores_gemma":[0.00049689756,0.00030008235,0.00009925355,0.00024153134,0.0001096523,0.000014106531,0.000075744254,0.00018126058,0.0000071492104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011802595,0.00054931326,0.9772821,0.00017617362,0.00009166701,0.005765203,0.00007143373,0.0012224445,0.00987788,0.00010602196,0.0033748702,0.0003026043],"study_design_scores_gemma":[0.0032706647,0.00003580846,0.9836882,0.0003646147,0.000045314897,0.000004144381,0.00011182996,0.00089224847,0.009232534,0.000042435335,0.001981391,0.00033082976],"about_ca_topic_score_codex":0.000038803424,"about_ca_topic_score_gemma":0.0014243381,"teacher_disagreement_score":0.006406055,"about_ca_system_score_codex":0.000182955,"about_ca_system_score_gemma":0.0015160445,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W3166958902","doi":"10.1093/crocol/otab038","title":"The Great Debate With IBD Biosimilars","year":2021,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biosimilar; Medicine; Internal medicine","score_opus":0.04654549297425101,"score_gpt":0.3287366330887108,"score_spread":0.2821911401144598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166958902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019841352,0.99174017,0.000048088747,0.00048204255,0.0010945225,0.00068287906,0.00027361125,0.000080443235,0.0055962424],"genre_scores_gemma":[0.0000027360481,0.9738232,0.00035021047,0.0006011222,0.00013457972,0.00016311537,0.0001786622,0.000077083365,0.024669327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623907,0.0011635253,0.00073037023,0.00081223814,0.000085702675,0.0009690919],"domain_scores_gemma":[0.9972926,0.0010569884,0.00033386596,0.0010451551,0.00018306966,0.000088360764],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005738038,0.00069586973,0.002114203,0.000096787226,0.0006853629,0.00018397723,0.0007765177,0.0011290616,0.0013312754],"category_scores_gemma":[0.00019356869,0.0003635669,0.0007732328,0.00054890476,0.0011068798,0.00004499147,0.00030492406,0.0011083644,0.00035783605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003789974,0.0000388097,0.000002444203,0.0009700005,0.0010231392,0.00025590148,0.000010441499,1.1847651e-8,0.0000015376199,0.0017702646,0.04118473,0.9547048],"study_design_scores_gemma":[0.00028103674,0.00012916872,0.00004282433,0.0045951093,0.0016791965,0.0009979346,0.00002502822,1.1225295e-7,0.000055474124,0.00007902133,0.9915921,0.00052300264],"about_ca_topic_score_codex":0.000024794415,"about_ca_topic_score_gemma":0.00009637136,"teacher_disagreement_score":0.9541818,"about_ca_system_score_codex":0.00011612166,"about_ca_system_score_gemma":0.00057494873,"threshold_uncertainty_score":0.9998816},"labels":[],"label_agreement":null},{"id":"W3170292850","doi":"10.1093/crocol/otab033","title":"Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?","year":2021,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Health care; Medicine; Psychology","score_opus":0.02428948243270657,"score_gpt":0.28377634981217503,"score_spread":0.25948686737946847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170292850","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3510796,0.009681601,0.000094642244,0.00035073413,0.6158625,0.0033368869,0.017259689,0.00024783626,0.0020864855],"genre_scores_gemma":[0.113452874,0.0029102233,0.001260942,0.00089637295,0.6757645,0.00080918794,0.20049183,0.00056843227,0.0038456132],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968377,0.00018939025,0.000533401,0.001291535,0.0005960638,0.0005519065],"domain_scores_gemma":[0.996369,0.000024391062,0.00059674465,0.00203833,0.00072874496,0.00024279163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002111293,0.00041730984,0.0004053063,0.00009198412,0.00014617913,0.00011149403,0.0005074152,0.0009565346,0.000052528154],"category_scores_gemma":[0.00066675904,0.00045054243,0.00007846937,0.00020454584,0.000079922895,0.000013783749,0.00049151294,0.00046516783,0.0000099672225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005008167,0.00014952233,0.0038356627,0.0005304998,0.0001658915,0.0038824973,0.00010073575,0.000021709471,0.000022026834,0.000006089891,0.99060816,0.00017638778],"study_design_scores_gemma":[0.00086408865,0.000115906136,0.023835786,0.0004741786,0.00013733709,0.00001693094,0.00032959887,0.000053173146,0.00010372087,0.0000053504873,0.9735277,0.0005361776],"about_ca_topic_score_codex":0.00037209754,"about_ca_topic_score_gemma":0.0072766272,"teacher_disagreement_score":0.23762675,"about_ca_system_score_codex":0.00018949439,"about_ca_system_score_gemma":0.0029549415,"threshold_uncertainty_score":0.99979466},"labels":[],"label_agreement":null},{"id":"W3177828927","doi":"10.1093/crocol/otab043","title":"Using Patient Completed Screening Tools to Predict Risk of Malnutrition in Patients With Inflammatory Bowel Disease","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of Calgary","funders":"University Hospital Foundation; Government of Alberta","keywords":"Malnutrition; Medicine; Ulcerative colitis; Inflammatory bowel disease; Body mass index; Internal medicine; Receiver operating characteristic; Gold standard (test); Ambulatory; Crohn's disease; Disease","score_opus":0.03723981018318229,"score_gpt":0.2898548382395403,"score_spread":0.252615028056358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177828927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996849,0.0001962927,0.0009415098,0.00025762274,0.000088622124,0.0010231321,0.00042397162,0.000040881838,0.00017897952],"genre_scores_gemma":[0.99146897,0.000028427949,0.007203721,0.00085632165,0.0000704918,0.000051468833,0.00027714,0.000026590636,0.000016860618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998293,0.00013161733,0.0005227918,0.0002937113,0.00042032183,0.00033855176],"domain_scores_gemma":[0.99860865,0.00006301165,0.00016425163,0.000284621,0.00046003895,0.00041942685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012794488,0.00014279832,0.00031352462,0.00021376325,0.00010759457,0.00002676369,0.000047021615,0.000055663724,0.00011828542],"category_scores_gemma":[0.00020488419,0.00014815139,0.00006021885,0.00033957712,0.000058977337,0.0001298097,0.000056967434,0.0002035395,0.000004675323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002701375,0.00045371338,0.9909432,0.00072959834,0.000026839007,0.00025692902,0.0002461774,0.00013207775,0.00007993447,0.00009731249,0.00029740133,0.0040354743],"study_design_scores_gemma":[0.004918235,0.00025871125,0.98885936,0.0028076745,0.00006841754,0.0000061698906,0.0001789366,0.0009150135,0.00021940697,0.00006273986,0.0015636747,0.00014165339],"about_ca_topic_score_codex":0.00007551256,"about_ca_topic_score_gemma":0.000046689347,"teacher_disagreement_score":0.006262211,"about_ca_system_score_codex":0.00017450236,"about_ca_system_score_gemma":0.00024829482,"threshold_uncertainty_score":0.60414386},"labels":[],"label_agreement":null},{"id":"W3178513091","doi":"10.1093/crocol/otab049","title":"Adalimumab, Infliximab, and Vedolizumab in Treatment of Ulcerative Colitis: A Long-Term Retrospective Study in a Tertiary Referral Center","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Vedolizumab; Adalimumab; Infliximab; Medicine; Ulcerative colitis; Discontinuation; Internal medicine; Adverse effect; Retrospective cohort study; Population; Golimumab; Disease","score_opus":0.012483945811137171,"score_gpt":0.2762410478711064,"score_spread":0.2637571020599693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178513091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974107,0.0004245281,0.0000032871246,0.0000348448,0.0000833473,0.00090082124,0.00016913685,0.000009107217,0.00096420024],"genre_scores_gemma":[0.9988677,0.00020407389,0.000028112028,0.00008371468,0.00008180198,0.0002730903,0.00013925125,0.000029227785,0.00029305895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981211,0.0003197205,0.00043002283,0.0005929212,0.00015597261,0.00038028506],"domain_scores_gemma":[0.9991876,0.000011243923,0.00009918975,0.0004274594,0.00015197451,0.00012253912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009275257,0.00025730912,0.0003539608,0.000098722645,0.00004750813,0.000039471943,0.00010010521,0.00013813627,0.00005087699],"category_scores_gemma":[0.00005790964,0.0002743897,0.00008612705,0.00012744893,0.00014528002,0.00001527315,0.0001426077,0.00009059793,0.0000031455556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027606497,0.0016116727,0.985891,0.000053068114,0.00010202956,0.0047516488,0.002169526,0.0000033758345,0.001170671,0.000079783575,0.00004162693,0.0013649781],"study_design_scores_gemma":[0.00791024,0.0006279974,0.98697734,0.00009004769,0.000029258179,0.000056450124,0.0007074025,0.000010042611,0.0031801895,0.000067376954,0.00010077142,0.00024288344],"about_ca_topic_score_codex":0.00018459416,"about_ca_topic_score_gemma":0.018502913,"teacher_disagreement_score":0.01831832,"about_ca_system_score_codex":0.00027218883,"about_ca_system_score_gemma":0.000313161,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W3201481843","doi":"10.1093/crocol/otz021","title":"Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Inflammatory bowel disease; Medicine; Intensive care medicine; Adverse effect; Current (fluid); Adverse Outcome Pathway; Disease; Outcome (game theory); Internal medicine; Engineering","score_opus":0.00629979692303997,"score_gpt":0.24278031332370123,"score_spread":0.23648051640066126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201481843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96241343,0.035439942,0.0000011173796,0.0001336358,0.00006795604,0.0016092142,0.00029957513,0.0000031023476,0.0000320242],"genre_scores_gemma":[0.9835757,0.015946247,0.000014921801,0.00017287325,0.0000626178,0.0000828586,0.00008477097,0.0000131031775,0.00004688153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986312,0.00048289174,0.000260268,0.0003557426,0.000118795106,0.00015109484],"domain_scores_gemma":[0.9990525,0.000012943857,0.00019367298,0.00046938602,0.00017523266,0.00009624047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015701436,0.00020340754,0.00026101863,0.00001971614,0.0000800113,0.00002085427,0.00023353066,0.00006826347,0.00001623476],"category_scores_gemma":[0.00005485837,0.0000993764,0.00008158726,0.0000536613,0.0003933515,0.000020083122,0.00023081929,0.00011302788,4.5827662e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064064385,0.00038373863,0.98637015,0.0004553847,0.000108248416,0.000014473192,0.002373663,0.000010640902,0.00015740193,0.00045695464,0.000042461965,0.0032204553],"study_design_scores_gemma":[0.0034479334,0.00026880368,0.9927966,0.0004892511,0.00005463876,0.0000018385232,0.0004725605,0.000008558643,0.000031182266,0.000017275439,0.0022732841,0.00013808],"about_ca_topic_score_codex":0.000014523898,"about_ca_topic_score_gemma":0.000017874221,"teacher_disagreement_score":0.021162292,"about_ca_system_score_codex":0.000025617348,"about_ca_system_score_gemma":0.00010360133,"threshold_uncertainty_score":0.40524518},"labels":[],"label_agreement":null},{"id":"W4224036526","doi":"10.1093/crocol/otac014","title":"Yoga in Patients With Inflammatory Bowel Disease: A Narrative Review","year":2022,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychosocial; Anxiety; Psychological intervention; Randomized controlled trial; Inflammatory bowel disease; Depression (economics); Physical therapy; Intervention (counseling); Disease; Alternative medicine; Irritable bowel syndrome; Crohn's disease; Clinical trial; Intensive care medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.03851490115680113,"score_gpt":0.34332331430550245,"score_spread":0.30480841314870133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224036526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008310623,0.9917377,7.0819834e-7,0.00012698433,0.00031059398,0.0046168235,0.00039545115,0.000045658842,0.0019349942],"genre_scores_gemma":[0.00006874765,0.99302447,0.000014631563,0.0006191797,0.0002872419,0.003119214,0.001496977,0.000065749184,0.0013038084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686575,0.00035100145,0.00090086967,0.00066662964,0.00074351527,0.0004722556],"domain_scores_gemma":[0.9983665,0.00022022869,0.00043580547,0.0005674196,0.00012380253,0.00028626516],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002697414,0.0006074624,0.0023566796,0.00026781953,0.00020630231,0.000011912943,0.00025604438,0.00002568131,0.0051880237],"category_scores_gemma":[0.00027224363,0.00043857822,0.00035476213,0.0004779546,0.00021807107,0.00008430328,0.000308727,0.000738947,0.000034817513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045310208,0.0005011305,0.024629937,0.17334726,0.0008795923,0.0021988456,0.00069683057,7.160958e-8,7.316565e-10,0.00016223914,0.021465804,0.77566516],"study_design_scores_gemma":[0.0014162251,0.00045154127,0.093950324,0.11289476,0.0013550249,0.000011090451,0.00013660523,1.0450251e-7,3.9930224e-9,0.000009143323,0.7894539,0.00032127628],"about_ca_topic_score_codex":0.000024669347,"about_ca_topic_score_gemma":0.00004707488,"teacher_disagreement_score":0.7753439,"about_ca_system_score_codex":0.0005602177,"about_ca_system_score_gemma":0.0007128001,"threshold_uncertainty_score":0.9998066},"labels":[],"label_agreement":null},{"id":"W4281781505","doi":"10.1093/crocol/otac016","title":"Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Quality of life (healthcare); Internal medicine; Calprotectin; Gastroenterology; Clinical trial; Placebo; Faecal calprotectin; Randomized controlled trial; Disease; Defecation; Physical therapy; Alternative medicine; Pathology","score_opus":0.016091006373910224,"score_gpt":0.3182580153888012,"score_spread":0.302167009014891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281781505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997942,0.000025808298,0.0000030760045,0.0000117220325,0.00007133455,0.00045180996,0.001009459,0.000004109248,0.00048068736],"genre_scores_gemma":[0.9995282,0.000012695122,0.000024992132,0.00011487163,0.000022458556,0.000045832756,0.00012340343,0.000016568096,0.000110953035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824125,0.00043634584,0.00056765764,0.0003067101,0.00023576428,0.00021230553],"domain_scores_gemma":[0.9990361,0.000056102905,0.00027048157,0.00033792347,0.00014458722,0.00015484895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034122882,0.00014972032,0.0003378785,0.00005261752,0.000060492977,0.000006604437,0.00013176733,0.00007265693,0.00013999942],"category_scores_gemma":[0.00034398897,0.0001347169,0.00016188704,0.000069690155,0.00019562055,0.00000528335,0.00015026954,0.00012147271,9.66994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070143715,0.0006312827,0.9912755,0.00003000318,0.0001405601,0.000014799127,0.00007347167,0.000032719618,0.000026554002,0.00029309865,0.0002058005,0.0002618481],"study_design_scores_gemma":[0.0028716766,0.0013501747,0.99538577,0.000008448232,0.000013245398,3.4713918e-7,0.0000636256,0.0000040894643,0.000041111096,0.000034245404,0.000077532095,0.00014971572],"about_ca_topic_score_codex":0.00025035843,"about_ca_topic_score_gemma":0.000340854,"teacher_disagreement_score":0.0041426946,"about_ca_system_score_codex":0.000046492336,"about_ca_system_score_gemma":0.00037571837,"threshold_uncertainty_score":0.5493596},"labels":[],"label_agreement":null},{"id":"W4282960986","doi":"10.1093/crocol/otac021","title":"Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Cohort; Health care; Retrospective cohort study; Emergency medicine; Internal medicine; Healthcare system; Disease; Emergency department","score_opus":0.0156862718341254,"score_gpt":0.25853723206963486,"score_spread":0.24285096023550945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955098,0.00008855977,0.000001197469,0.00003653683,0.00009082429,0.00078331557,0.0033586565,0.00002046035,0.000110637084],"genre_scores_gemma":[0.9951628,0.000029848154,0.000010397125,0.00029634757,0.000024526738,0.0003094535,0.0038528848,0.000028559232,0.00028522447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984577,0.00028956635,0.0002728573,0.0004223851,0.00024131908,0.00031621964],"domain_scores_gemma":[0.9990566,0.000020371232,0.0002541688,0.00024666789,0.00012405132,0.0002981693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009594519,0.00021910155,0.00020096241,0.000103975435,0.00026866933,0.000018373385,0.00013051255,0.000083867766,0.00025195006],"category_scores_gemma":[0.00008075434,0.00018555096,0.000081620004,0.00014133281,0.00019691969,0.0000065093154,0.00013313364,0.00008817654,0.0000027142923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071605174,0.0008446811,0.99013525,0.00003379786,0.00018994178,0.00050876,0.000050126222,0.00003935625,0.000023629927,0.00007789052,0.0004763866,0.0004596585],"study_design_scores_gemma":[0.0032833857,0.0014075132,0.99411213,0.000029862285,0.0000585456,0.0000013796122,0.000059696496,0.000015237267,0.00011844994,0.000010633682,0.0006924375,0.00021072738],"about_ca_topic_score_codex":0.00008626637,"about_ca_topic_score_gemma":0.00015973447,"teacher_disagreement_score":0.003976878,"about_ca_system_score_codex":0.0002887684,"about_ca_system_score_gemma":0.00038604686,"threshold_uncertainty_score":0.75665486},"labels":[],"label_agreement":null},{"id":"W4283795631","doi":"10.1093/crocol/otac025","title":"Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development","keywords":"Medicine; Ulcerative colitis; Ustekinumab; Inflammatory bowel disease; Pregnancy; Disease; Crohn's disease; Clinical trial; Obstetrics; Internal medicine; Gastroenterology; Infliximab","score_opus":0.05750242424892665,"score_gpt":0.37205219623180075,"score_spread":0.3145497719828741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283795631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812675,0.005328009,0.000014318377,0.0009976514,0.00071872264,0.0035035012,0.0010827348,0.000067410656,0.00016088256],"genre_scores_gemma":[0.9928611,0.0011274766,0.00007781115,0.0016757237,0.00013726707,0.0024140207,0.00014080963,0.000060062026,0.0015057456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993869,0.0019110846,0.0017683948,0.00091470004,0.0006910534,0.0008457556],"domain_scores_gemma":[0.9966695,0.0009700563,0.00033067405,0.000778722,0.000056672252,0.0011943951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018837441,0.00036056864,0.0012433294,0.00039892676,0.00009424166,0.00006360737,0.0003088279,0.00016050813,0.00082592666],"category_scores_gemma":[0.0044823815,0.00037622146,0.00020819412,0.0004939989,0.00023929724,0.0003445199,0.00035835148,0.0008130618,0.000027779639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083277,0.0009452912,0.9088671,0.00023924626,0.00012384723,0.011044949,0.030124018,0.00003694679,0.000004351868,0.0005397284,0.0011838477,0.03856294],"study_design_scores_gemma":[0.012409415,0.0002607011,0.9756566,0.0032279568,0.00008064438,0.000006010335,0.003367773,0.00005600461,0.0000023606492,0.0015070442,0.0030532265,0.0003722604],"about_ca_topic_score_codex":0.000662296,"about_ca_topic_score_gemma":0.0011009453,"teacher_disagreement_score":0.06678947,"about_ca_system_score_codex":0.0009302076,"about_ca_system_score_gemma":0.001707277,"threshold_uncertainty_score":0.999869},"labels":[],"label_agreement":null},{"id":"W4289667225","doi":"10.1093/crocol/otac031","title":"Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?","year":2022,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; McMaster University","funders":"","keywords":"Inflammatory bowel disease; Medicine; Intensive care medicine; Inflammatory Bowel Diseases; Disease; Internal medicine","score_opus":0.019039280022303463,"score_gpt":0.30368983946486977,"score_spread":0.2846505594425663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289667225","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06177762,0.0083087785,0.0001463359,0.0055946703,0.91056293,0.0045188023,0.00755629,0.00019078198,0.0013437655],"genre_scores_gemma":[0.02225827,0.0028918558,0.00021334141,0.0027803478,0.93610203,0.0029218227,0.0045616217,0.00036103296,0.027909702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466074,0.000569753,0.00101821,0.0014671371,0.0014310733,0.00085311034],"domain_scores_gemma":[0.99475586,0.0001938489,0.0006092293,0.0022896724,0.0013540479,0.0007973525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010700504,0.00075906015,0.00046013834,0.0001439067,0.0006591761,0.00039612217,0.0018554906,0.0007500001,0.0007109824],"category_scores_gemma":[0.006466466,0.00071189477,0.0005558696,0.00019667333,0.00027941613,0.000018212253,0.0012023085,0.00084258686,0.00028869696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013915015,0.00006308539,0.00032670394,0.00020411315,0.00013299382,0.0006558153,0.000110243025,0.00007828318,0.00014891848,0.000081695056,0.99470794,0.002098733],"study_design_scores_gemma":[0.0007818374,0.00019336048,0.012893169,0.00019239486,0.00020609946,0.0000025424858,0.0003028821,0.000022678378,0.00004124009,0.00024004122,0.98425865,0.000865124],"about_ca_topic_score_codex":0.000039980343,"about_ca_topic_score_gemma":0.00047419214,"teacher_disagreement_score":0.039519355,"about_ca_system_score_codex":0.00021868313,"about_ca_system_score_gemma":0.004006542,"threshold_uncertainty_score":0.99953324},"labels":[],"label_agreement":null},{"id":"W4296700750","doi":"10.1093/crocol/otac036","title":"Exploring Patient Perspectives on a 12-Week Online, Stress Reduction Intervention in Inflammatory Bowel Disease","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University Hospital Foundation; American College of Gastroenterology","keywords":"Inflammatory bowel disease; Intervention (counseling); Reduction (mathematics); Medicine; Disease; Stress reduction; Internal medicine; Gastroenterology; Physical therapy; Nursing; Mathematics","score_opus":0.023808394587964517,"score_gpt":0.24473368918580235,"score_spread":0.22092529459783783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296700750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775684,0.0004812524,0.000010398815,0.00006004457,0.0005045958,0.0005024296,0.0003634223,0.000037660757,0.00028337288],"genre_scores_gemma":[0.99798125,0.000100583165,0.000025301146,0.00006239686,0.0002703661,0.00082932314,0.00044344424,0.000041565254,0.00024575111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982504,0.0002667431,0.0003345885,0.0005498922,0.00027433422,0.0003240363],"domain_scores_gemma":[0.9991728,0.0000066056155,0.00013134426,0.00043621482,0.00007333915,0.00017966953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013650344,0.00020121438,0.00011107176,0.00016557329,0.00020553493,0.00004355155,0.00018891168,0.000042523305,0.00011798607],"category_scores_gemma":[0.00009596059,0.0002511413,0.00017025537,0.000082372666,0.00008188244,0.000024754148,0.00025762917,0.00021492568,0.000009341664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112286344,0.043380212,0.40176654,0.003185414,0.0013234103,0.023097727,0.060980428,0.112358,0.061417792,0.02073569,0.013864909,0.14560355],"study_design_scores_gemma":[0.001100841,0.00040834432,0.9769705,0.00009283363,0.000021440863,0.000010025928,0.015152942,0.00014659189,0.001323478,0.000094757735,0.004324574,0.0003536753],"about_ca_topic_score_codex":0.00004594609,"about_ca_topic_score_gemma":0.00010879482,"teacher_disagreement_score":0.57520396,"about_ca_system_score_codex":0.00026400958,"about_ca_system_score_gemma":0.00014434471,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W4310288520","doi":"10.1093/crocol/otac045","title":"Patient-Centered Access to IBD Care: A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Ottawa; Dalhousie University; University of Toronto; McGill University; University of Calgary; University of Alberta; University of Saskatchewan; Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Specialty; Medicine; Health care; Thematic analysis; Qualitative research; Family medicine; Focus group; Context (archaeology); Nursing; Geography","score_opus":0.01748449446885665,"score_gpt":0.31906190180490895,"score_spread":0.3015774073360523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310288520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995762,0.00016302004,0.000027493026,0.00007156168,0.0003780935,0.0012598095,0.0005248692,0.00002769237,0.001785474],"genre_scores_gemma":[0.99688864,0.0000021032001,0.000036683166,0.0012528179,0.00010517384,0.001014384,0.00024339648,0.000036872432,0.00041991952],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9980747,0.00050295476,0.0002648844,0.00050683174,0.00029569693,0.0003549328],"domain_scores_gemma":[0.999008,0.00001117327,0.000086626416,0.00052483176,0.00016367101,0.00020567018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014890928,0.0001808599,0.00014898801,0.00006621045,0.0003233479,0.0000859456,0.0004278223,0.00003810454,0.00028528148],"category_scores_gemma":[0.00008169207,0.00021271913,0.00009839542,0.0001436319,0.00004408087,0.0000075255834,0.0009920091,0.00010360305,0.000037633123],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021347841,0.006017238,0.08911918,0.00038646456,0.0013340117,0.008068511,0.5964993,0.001076727,0.022757698,0.0010878501,0.22466256,0.027642574],"study_design_scores_gemma":[0.0032737548,0.0023540426,0.58046526,0.000015426282,0.00007948283,0.00001866218,0.20489655,0.0000060962466,0.0036790776,0.00010888361,0.20419686,0.00090591266],"about_ca_topic_score_codex":0.00009131926,"about_ca_topic_score_gemma":0.0002931255,"teacher_disagreement_score":0.49134606,"about_ca_system_score_codex":0.000107035434,"about_ca_system_score_gemma":0.00019805392,"threshold_uncertainty_score":0.8674434},"labels":[],"label_agreement":null},{"id":"W4311037775","doi":"10.1093/crocol/otac046","title":"Models of Care for Inflammatory Bowel Disease: A National Cross-sectional Survey to Characterize the Landscape of Inflammatory Bowel Disease Care in Canada","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Saskatchewan; Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Crohn's and Colitis Canada","keywords":"Respondent; Medicine; Referral; Collaborative Care; Family medicine; Inflammatory bowel disease; Descriptive statistics; Cross-sectional study; Audit; Disease; Nursing; Primary care; Internal medicine; Pathology","score_opus":0.011468123633281837,"score_gpt":0.242486657677117,"score_spread":0.23101853404383516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311037775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747053,0.0010047493,0.000017228162,0.000033200617,0.00033000694,0.0011765844,0.022601644,0.000009398196,0.00012192134],"genre_scores_gemma":[0.99432427,0.000016526466,0.0000142791,0.000306699,0.00016656038,0.0011948324,0.0038024788,0.000049233186,0.00012512675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974574,0.00026597927,0.00063483615,0.00051366055,0.00071595795,0.00041218885],"domain_scores_gemma":[0.9976788,0.00007551276,0.000257854,0.0005346696,0.001105612,0.00034753917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038769713,0.00025772836,0.00021818368,0.00011367767,0.00029270037,0.00003263944,0.0005555551,0.00006818929,0.00008722198],"category_scores_gemma":[0.0003353194,0.00027253194,0.00018221399,0.00014319422,0.00012770225,0.000021161,0.00037889252,0.00014461929,0.0000010098263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067931274,0.000053259177,0.95797503,0.00066234265,0.00006044715,0.00010199685,0.00037041982,0.031951092,0.0005677528,0.00039746208,0.0010094071,0.00005763865],"study_design_scores_gemma":[0.0010791485,0.00006133108,0.9940136,0.000025191532,0.000016734322,0.0000022337915,0.0004391093,0.0006706405,0.00017416956,0.000075491465,0.003149727,0.0002926236],"about_ca_topic_score_codex":0.011022224,"about_ca_topic_score_gemma":0.25860247,"teacher_disagreement_score":0.24758025,"about_ca_system_score_codex":0.00048577538,"about_ca_system_score_gemma":0.009294794,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W4319078751","doi":"10.1093/crocol/otad004","title":"Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Echosens","keywords":"Nonalcoholic fatty liver disease; Medicine; Transient elastography; Internal medicine; Gastroenterology; Ulcerative colitis; Odds ratio; Inflammatory bowel disease; Population; Fibrosis; Liver disease; Fatty liver; Body mass index; Disease; Liver fibrosis","score_opus":0.014606689658488286,"score_gpt":0.24597749336358624,"score_spread":0.23137080370509794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319078751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791815,0.017384596,0.0000029458693,0.00014569929,0.0001373329,0.001194769,0.0011778537,0.00031654752,0.00045869913],"genre_scores_gemma":[0.98988277,0.007616054,0.00001896201,0.00035520882,0.00030603082,0.00094348966,0.0005683677,0.00006475455,0.00024437305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973863,0.00021492482,0.00038431108,0.00067758496,0.00068180653,0.000655094],"domain_scores_gemma":[0.9975913,0.00022201904,0.00008100542,0.0009114602,0.00012521552,0.0010689872],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019111406,0.00035502136,0.00057030184,0.00034189195,0.00018209298,0.000079306286,0.00015839368,0.00008937354,0.00034631332],"category_scores_gemma":[0.0003517389,0.00032912075,0.0008205207,0.0004867084,0.00018631175,0.00018946131,0.00017417801,0.00017724255,0.0010209783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005830462,0.0009306053,0.97044575,0.0003515294,0.0008029592,0.016013924,0.00013109185,0.000117353375,0.0000014236491,0.00026928476,0.003862004,0.006491024],"study_design_scores_gemma":[0.003227655,0.00006446475,0.9838772,0.00037586055,0.0018166979,0.000013443767,0.00007538905,0.00027334623,0.000027360042,0.000267085,0.009661289,0.00032019694],"about_ca_topic_score_codex":0.0030299905,"about_ca_topic_score_gemma":0.00016370416,"teacher_disagreement_score":0.01600048,"about_ca_system_score_codex":0.00028710964,"about_ca_system_score_gemma":0.0004547394,"threshold_uncertainty_score":0.9999161},"labels":[],"label_agreement":null},{"id":"W4321498772","doi":"10.1093/crocol/otad006","title":"The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Genentech; Norman Collisson Foundation; Eisai; UK-India Education and Research Initiative; Cilag; Coloplast; Mylan; Celltrion; Wellcome Trust; Leona M. and Harry B. Helmsley Charitable Trust; Janssen Pharmaceuticals; Gilead Sciences; Celgene; Biogen; GlaxoSmithKline; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Inflammatory bowel disease; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.009228585759811274,"score_gpt":0.24883796672918476,"score_spread":0.23960938096937348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321498772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969932,0.00011589128,0.000011274106,0.000049631566,0.00020687573,0.0011581046,0.0013371703,0.000024424866,0.000103467835],"genre_scores_gemma":[0.9987883,0.000049830527,0.000025428213,0.000081998194,0.000041057294,0.00025028497,0.0004178526,0.000029313287,0.00031592062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986095,0.00006799085,0.00042739086,0.00027121595,0.00029856342,0.00032536822],"domain_scores_gemma":[0.9980357,0.000095330906,0.00032622792,0.0008174585,0.00058605644,0.00013917097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009253226,0.00018819174,0.00015531071,0.000029781795,0.00021786422,0.000034004846,0.00026080973,0.000058553767,0.000004920401],"category_scores_gemma":[0.00032125285,0.00011665989,0.00018956201,0.00014084422,0.0003224372,0.00001004341,0.00016243773,0.00004300687,0.0000023200269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022762087,0.000044060387,0.9932594,0.00011678415,0.00019858118,0.000035417885,0.000087628374,0.00018138479,0.000030292505,0.0006070412,0.002066469,0.0010967334],"study_design_scores_gemma":[0.0009100433,0.000073637195,0.98538256,0.000026132202,0.00012124733,1.5992839e-7,0.00017218154,0.000025040881,0.000256087,0.00006210568,0.012825979,0.00014483937],"about_ca_topic_score_codex":0.00006555984,"about_ca_topic_score_gemma":0.0009421989,"teacher_disagreement_score":0.01075951,"about_ca_system_score_codex":0.000037688995,"about_ca_system_score_gemma":0.00033754794,"threshold_uncertainty_score":0.47572523},"labels":[],"label_agreement":null},{"id":"W4322155256","doi":"10.1093/crocol/otad012","title":"Crohn’s Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Saskatchewan","funders":"Genentech; Pfizer; Dr. Falk Pharma; National Institute for Health and Care Research; Leona M. and Harry B. Helmsley Charitable Trust; F. Hoffmann-La Roche; Celltrion; AbbVie; Celgene; Gilead Sciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Crohn's disease; Disease; Qualitative research; Medicine; Crohn disease; Intensive care medicine; Internal medicine; Sociology","score_opus":0.023632018261643906,"score_gpt":0.3207818642203414,"score_spread":0.2971498459586975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322155256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985744,0.000120910016,0.000008112901,0.000036539095,0.00029226544,0.0005546464,0.00017406806,0.000056190238,0.000182866],"genre_scores_gemma":[0.9983204,0.00004453586,0.000037160065,0.000043055552,0.00022605622,0.0008383833,0.0001703035,0.000023510584,0.00029657388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984037,0.00021066554,0.00020403166,0.0005628558,0.00034006778,0.00027863708],"domain_scores_gemma":[0.9988529,0.000018428356,0.00008269047,0.00035864543,0.00016324128,0.00052407535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012667416,0.00020179947,0.00011388394,0.000067601955,0.00018934495,0.00014583395,0.00024074219,0.000036263602,0.00004243786],"category_scores_gemma":[0.000119445314,0.00017737097,0.00003956898,0.000093121445,0.00023051369,0.000037205176,0.0001751278,0.000055945162,0.000012652532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010685553,0.0012987095,0.81449485,0.000112235226,0.00032349039,0.0075868564,0.15803693,0.00011958195,0.00035673237,0.0003873393,0.0007305749,0.005867161],"study_design_scores_gemma":[0.00050691987,0.00026739074,0.9056399,0.000026208274,0.00002983578,0.0000010696434,0.09239467,0.000033128534,0.00012813185,0.0001251247,0.0006065123,0.00024109404],"about_ca_topic_score_codex":0.00003091132,"about_ca_topic_score_gemma":0.000049775677,"teacher_disagreement_score":0.09114508,"about_ca_system_score_codex":0.000020834219,"about_ca_system_score_gemma":0.00020093891,"threshold_uncertainty_score":0.7232978},"labels":[],"label_agreement":null},{"id":"W4322501149","doi":"10.1093/crocol/otad008","title":"Editorial: Pharmacotherapy for Obesity in Persons With Inflammatory Bowel Disease","year":2023,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Pharmacotherapy; Medicine; Inflammatory bowel disease; Obesity; Disease; Intensive care medicine; Internal medicine","score_opus":0.011515990335038079,"score_gpt":0.286782702715137,"score_spread":0.2752667123800989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322501149","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012695388,0.00045793047,0.000060950482,0.00038820496,0.98221284,0.0021746466,0.0015016425,0.0003238864,0.00018450292],"genre_scores_gemma":[0.0012856509,0.000286977,0.00016952188,0.000115826166,0.99318826,0.0008155344,0.0011116068,0.0001995466,0.00282708],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967097,0.00009193115,0.00049048226,0.00083942607,0.0010180512,0.0008504155],"domain_scores_gemma":[0.9969175,0.001139892,0.00020565234,0.00053758407,0.0005404312,0.0006589505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004595433,0.0005469482,0.00075379503,0.00028712366,0.00015956204,0.00008654009,0.00028004745,0.0005229581,0.00008995724],"category_scores_gemma":[0.002234765,0.00053036463,0.00030594782,0.00025728386,0.00028068162,0.00013078433,0.000057311034,0.0011343072,0.00005952391],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009734271,0.00034704804,0.0063465997,0.0018900828,0.00009262336,0.00041237875,0.00020320139,0.0000096745325,0.000009152666,0.000016759135,0.9807342,0.00020398475],"study_design_scores_gemma":[0.0071675302,0.000547117,0.049318228,0.0014552929,0.0003092865,0.000003035938,0.00016421851,0.000052085234,0.0000042475817,0.0001964654,0.94037145,0.00041106265],"about_ca_topic_score_codex":0.00041636956,"about_ca_topic_score_gemma":0.000855465,"teacher_disagreement_score":0.042971626,"about_ca_system_score_codex":0.00038589112,"about_ca_system_score_gemma":0.0026286256,"threshold_uncertainty_score":0.9997148},"labels":[],"label_agreement":null},{"id":"W4322730753","doi":"10.1093/crocol/otad009","title":"Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"AbbVie","keywords":"Medicine; Vedolizumab; Golimumab; Internal medicine; Maintenance therapy; Ustekinumab; Ulcerative colitis; Adverse effect; Placebo; Infliximab; Discontinuation; Adalimumab; Tofacitinib; Chemotherapy","score_opus":0.057001298517073674,"score_gpt":0.32664760811582083,"score_spread":0.26964630959874714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322730753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612695,0.00038076018,0.0014284365,0.000055029708,0.000049185845,0.001218273,0.0006577305,0.000021880522,0.00006173796],"genre_scores_gemma":[0.9973042,0.00014373224,0.0014749506,0.000074461415,0.000083217965,0.00025780266,0.00036662532,0.000030421788,0.00026456724],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984677,0.00021407728,0.00032020887,0.0005363042,0.0001093273,0.00035238542],"domain_scores_gemma":[0.99912804,0.000054158852,0.00017721037,0.00027442875,0.00018615583,0.00017998829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017885838,0.00025357818,0.00065544527,0.00009982202,0.0003161571,0.00004262951,0.00006862126,0.00012397829,0.000019681329],"category_scores_gemma":[0.000038407114,0.00023072038,0.00022393232,0.00026512495,0.00012597464,0.00001979629,0.000075152886,0.000041933432,7.046313e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3281794,0.0010531724,0.011020621,0.000416862,0.2268699,0.000244732,0.026916344,0.2972453,0.031051382,0.00244094,0.0016082545,0.07295311],"study_design_scores_gemma":[0.0017173253,0.00056371634,0.97258425,0.000009837128,0.008652737,0.0000060019665,0.0006904048,0.003469229,0.010530865,0.00022206419,0.0012293254,0.00032425535],"about_ca_topic_score_codex":0.00006351801,"about_ca_topic_score_gemma":0.0017919035,"teacher_disagreement_score":0.9615636,"about_ca_system_score_codex":0.00010630643,"about_ca_system_score_gemma":0.00008747502,"threshold_uncertainty_score":0.94085044},"labels":[],"label_agreement":null},{"id":"W4361207010","doi":"10.1093/crocol/otad017","title":"The Impact of Confounders on Symptom–Endoscopic Discordances in Crohn’s Disease","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Advancing Translational Sciences; University of California, San Francisco; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Seres Therapeutics; Crohn's and Colitis Foundation; Pfizer; Genentech; Crohn's and Colitis Foundation of America; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Internal medicine; Medicine; Gastroenterology; Crohn's disease; Diarrhea; Confounding; Abdominal pain; Small intestinal bacterial overgrowth; Disease; Breath test; Severity of illness; Irritable bowel syndrome","score_opus":0.011554231961621158,"score_gpt":0.2909510009977366,"score_spread":0.27939676903611543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361207010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971734,0.0002606325,0.000004821259,0.00008418191,0.00020233644,0.0003825739,0.00013734988,0.000023668314,0.0017309795],"genre_scores_gemma":[0.99830824,0.00025394963,0.0000026532512,0.000075575634,0.000115627896,0.000114123875,0.00009690975,0.000026203106,0.0010067446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870175,0.00011068561,0.00026871279,0.0003095274,0.00017510366,0.0004341918],"domain_scores_gemma":[0.9990753,0.00005622526,0.000096229705,0.0005332705,0.000058689184,0.000180266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016699947,0.00018391351,0.0001488114,0.000068122135,0.00013304928,0.000055459917,0.00030049332,0.00006310482,0.00003065659],"category_scores_gemma":[0.00020499485,0.00013991089,0.00018705688,0.00016784346,0.00029923182,0.0000054768593,0.000104628096,0.00008462265,0.00005365225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008996055,0.00045451056,0.93090934,0.0003381861,0.00046543858,0.0038294336,0.00048520172,0.0039531407,0.0108587975,0.009838764,0.020286297,0.0095848255],"study_design_scores_gemma":[0.00065987057,0.00007751384,0.99659926,0.000053125517,0.000011061234,8.9306775e-7,0.000118798074,0.00011562613,0.0006154635,0.0007558324,0.0008498439,0.00014274204],"about_ca_topic_score_codex":0.0001427169,"about_ca_topic_score_gemma":0.00043054883,"teacher_disagreement_score":0.06568988,"about_ca_system_score_codex":0.000059669554,"about_ca_system_score_gemma":0.00041960186,"threshold_uncertainty_score":0.57054},"labels":[],"label_agreement":null},{"id":"W4384281358","doi":"10.1093/crocol/otad033","title":"Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"GlaxoSmithKline Biologicals; American College of Gastroenterology","keywords":"Medicine; Inflammatory bowel disease; Confidence interval; Emergency department; Incidence (geometry); Ulcerative colitis; Health care; Propensity score matching; Rate ratio; Internal medicine; Disease","score_opus":0.013223371049524778,"score_gpt":0.282289147321991,"score_spread":0.26906577627246625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384281358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891186,0.000027207001,6.442503e-7,0.00016446665,0.000059908987,0.00047060256,0.00007955157,0.000028426397,0.00025732652],"genre_scores_gemma":[0.9992544,0.00015134313,0.0000063726743,0.000117550706,0.000045526373,0.000048383463,0.00016388755,0.000015045466,0.0001974772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921066,0.000083211475,0.00027795802,0.00016619384,0.00009423355,0.00016772264],"domain_scores_gemma":[0.99938977,0.00016028452,0.00006796307,0.00021893527,0.000042876225,0.0001202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015854537,0.00009885805,0.0001720105,0.0001339975,0.00005218454,0.000020944608,0.000045481116,0.000046024423,0.0000500641],"category_scores_gemma":[0.00003405248,0.000064833155,0.000042137915,0.00013645327,0.00021813487,0.00006610292,0.00003316827,0.00008321958,0.000037198366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031664126,0.00013440436,0.9933643,0.000040473213,0.000079300335,0.00012045167,0.00042200473,0.00006084909,2.9895727e-8,0.000035748362,0.00031666976,0.0051091653],"study_design_scores_gemma":[0.0023945188,0.00015678779,0.9847105,0.00011839588,0.000083567094,9.2684274e-7,0.00016978956,0.0005208971,0.0000014883831,0.00007347053,0.011705378,0.000064278574],"about_ca_topic_score_codex":0.0013433532,"about_ca_topic_score_gemma":0.0005159465,"teacher_disagreement_score":0.011388708,"about_ca_system_score_codex":0.000039770955,"about_ca_system_score_gemma":0.00007434018,"threshold_uncertainty_score":0.26438192},"labels":[],"label_agreement":null},{"id":"W4385618950","doi":"10.1093/crocol/otad043","title":"Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammatory bowel disease; Medicine; Disease; Inflammatory Bowel Diseases; Intensive care medicine; Family medicine; Pathology","score_opus":0.016154307590608468,"score_gpt":0.31417136503622467,"score_spread":0.2980170574456162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385618950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878025,0.00016447177,0.0005100922,0.0070403414,0.0004913001,0.0013164445,0.00009197471,0.0007179805,0.0018648981],"genre_scores_gemma":[0.9846011,0.000043055035,0.006206359,0.0029031483,0.00079999014,0.0003034848,0.00034692563,0.00010200559,0.0046939705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971622,0.00021026112,0.00048589206,0.00073787326,0.0005797252,0.000824046],"domain_scores_gemma":[0.9963165,0.0006554971,0.0001642453,0.0009242948,0.0006060586,0.0013334188],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058943394,0.0003646243,0.0004041937,0.00034917757,0.00029805457,0.0003261696,0.00029242362,0.0001232121,0.00046768162],"category_scores_gemma":[0.009855734,0.00038125095,0.000118618686,0.00070918887,0.00020176668,0.0005547429,0.00020054367,0.00051948865,0.0005235337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096396925,0.0018763073,0.34439772,0.004116545,0.000672558,0.032502484,0.049047712,0.000060846152,0.1241726,0.015713913,0.33943146,0.07836818],"study_design_scores_gemma":[0.0013509758,0.000651548,0.8532777,0.0008243148,0.0001804071,0.00035887444,0.005225353,0.00041252328,0.0010022281,0.0008018759,0.1354007,0.0005135017],"about_ca_topic_score_codex":0.00074836443,"about_ca_topic_score_gemma":0.0010765414,"teacher_disagreement_score":0.50887996,"about_ca_system_score_codex":0.00045705363,"about_ca_system_score_gemma":0.0009284711,"threshold_uncertainty_score":0.9998639},"labels":[],"label_agreement":null},{"id":"W4386008142","doi":"10.1093/crocol/otad034","title":"Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Dosing; Internal medicine; Post-hoc analysis; Crohn's disease; Gastroenterology; Clinical trial; Maintenance therapy; Disease; Chemotherapy","score_opus":0.07314988302568722,"score_gpt":0.38284115858999007,"score_spread":0.30969127556430287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386008142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776137,0.00070476474,0.0000060103953,0.00011681027,0.000090610534,0.0005254729,0.0005225128,0.000026738679,0.00024571197],"genre_scores_gemma":[0.99726325,0.0012563854,0.000278602,0.00008567246,0.00008527142,0.000066625755,0.0001876467,0.000042441145,0.00073408504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784744,0.00032972902,0.00056798075,0.0005212215,0.0002799879,0.000453664],"domain_scores_gemma":[0.99828446,0.00022536576,0.0002642463,0.0004736437,0.0005234657,0.00022879294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022872638,0.00026750212,0.00046224255,0.00025728063,0.00012118808,0.00005947295,0.0001347648,0.00011632916,0.0000328082],"category_scores_gemma":[0.0011967415,0.00027664096,0.00013051195,0.0003714479,0.0005906034,0.000035661877,0.00028700443,0.00012714707,0.0000058192827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12267261,0.0026381656,0.47440916,0.008178745,0.0048770513,0.096620485,0.0071633365,0.0017156923,0.23435144,0.010233433,0.028699977,0.0084398845],"study_design_scores_gemma":[0.0009636257,0.0001758211,0.9894516,0.00027938746,0.00015574874,0.000030375388,0.0005537781,0.00013188265,0.0073611243,0.000108066575,0.0005058178,0.0002828139],"about_ca_topic_score_codex":0.00053804053,"about_ca_topic_score_gemma":0.003987115,"teacher_disagreement_score":0.51504236,"about_ca_system_score_codex":0.00007269617,"about_ca_system_score_gemma":0.00060952647,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W4386260834","doi":"10.1093/crocol/otad045","title":"Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Ustekinumab; Medicine; Odds ratio; Maintenance therapy; Confidence interval; Internal medicine; Ulcerative colitis; Corticosteroid; Prednisone; Disease; Chemotherapy","score_opus":0.0204497148688626,"score_gpt":0.2542550695092782,"score_spread":0.23380535464041557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386260834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897146,0.00000960643,0.000012459497,0.000052139312,0.000015364747,0.00049955107,0.00038091178,0.000012460097,0.000046032274],"genre_scores_gemma":[0.998411,0.00012907002,0.00002789393,0.00013382878,0.0000118012,0.000086390784,0.0011495646,0.000010399337,0.00004006209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990811,0.00017627662,0.00018253614,0.00024624504,0.00011786856,0.00019602556],"domain_scores_gemma":[0.9994019,0.000068504,0.00010554747,0.00019357973,0.00016591023,0.00006453137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012322668,0.00011862501,0.00010347192,0.00009819424,0.0001222102,0.00003409557,0.000077956036,0.00006888121,0.000005739645],"category_scores_gemma":[0.00017031358,0.00008954355,0.000018097888,0.0002413194,0.00038221304,0.000016713655,0.00004840642,0.00007422476,0.0000010428133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076164347,0.00059935474,0.98052824,0.00023790829,0.00017914621,0.0004752294,0.0054148156,0.0010270254,0.0015816678,0.0006012246,0.0005176709,0.0012213142],"study_design_scores_gemma":[0.002170306,0.00024305245,0.9953587,0.00008742827,0.000018911504,0.000003135065,0.00072315615,0.00086323457,0.00028156312,0.000027798455,0.000111061614,0.00011167468],"about_ca_topic_score_codex":0.00009210536,"about_ca_topic_score_gemma":0.00043856268,"teacher_disagreement_score":0.01483047,"about_ca_system_score_codex":0.00002018862,"about_ca_system_score_gemma":0.00004089188,"threshold_uncertainty_score":0.365148},"labels":[],"label_agreement":null},{"id":"W4386950391","doi":"10.1093/crocol/otad050","title":"Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Gastroenterological Society of Australia; Celltrion; Australian Government; Celltrion Healthcare; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Calprotectin; Inflammatory bowel disease; Endoscopy; Sigmoidoscopy; Internal medicine; Disease; Observational study; Intensive care medicine; Colonoscopy; Colorectal cancer","score_opus":0.025405531874836927,"score_gpt":0.35444731117900097,"score_spread":0.32904177930416406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386950391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838066,0.0001904657,0.00016463928,0.000036110105,0.0002527384,0.0005625928,0.0000470474,0.00007231842,0.0002934216],"genre_scores_gemma":[0.9978318,0.0002851081,0.0004452395,0.00040820052,0.00035130407,0.00012597084,0.0003434455,0.000053944656,0.00015496298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972723,0.0003335924,0.0008369187,0.00076444616,0.00028951632,0.00050322036],"domain_scores_gemma":[0.99814504,0.0003040883,0.00020119005,0.0006229293,0.00013165074,0.0005951207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011703133,0.00026778394,0.00022514627,0.0001529656,0.00020032299,0.00013111219,0.00026557987,0.00020134411,0.0000870705],"category_scores_gemma":[0.0024807234,0.00028875636,0.00013231585,0.0001489026,0.00027681375,0.00003178381,0.00028189967,0.00024305715,0.000031516553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019571944,0.00018984471,0.97265875,0.0001235367,0.000032543558,0.0008417077,0.00009937899,0.00010992817,0.0017275618,0.00012581174,0.0016954234,0.020438328],"study_design_scores_gemma":[0.0009310702,0.00015861317,0.99128973,0.00017298988,0.00003748892,0.000013543886,0.00028463293,0.002320141,0.00006452591,0.000528651,0.003870795,0.0003277922],"about_ca_topic_score_codex":0.000004026391,"about_ca_topic_score_gemma":0.0001907416,"teacher_disagreement_score":0.020110536,"about_ca_system_score_codex":0.000066271874,"about_ca_system_score_gemma":0.00072535453,"threshold_uncertainty_score":0.9999564},"labels":[],"label_agreement":null},{"id":"W4388184549","doi":"10.1093/crocol/otad066","title":"Thiopurine exposure during pregnancy is not associated with anemia in infants born to mothers with IBD","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Thiopurine methyltransferase; Pregnancy; Medicine; Anemia; Obstetrics; Pediatrics; Inflammatory bowel disease; Internal medicine; Biology; Disease; Genetics","score_opus":0.01706048207461893,"score_gpt":0.27113676160345945,"score_spread":0.25407627952884054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388184549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915838,0.0002814401,0.00001349453,0.0019634224,0.000078870464,0.0010157923,0.00007620472,0.00028670364,0.0047002397],"genre_scores_gemma":[0.98951054,0.00015496874,0.000095013806,0.0011019926,0.00007206008,0.00022864966,0.00005513912,0.000061844854,0.008719777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979998,0.00004845411,0.0003262415,0.0004305962,0.000518819,0.00067610433],"domain_scores_gemma":[0.9987799,0.00007242166,0.00012153684,0.0005004606,0.00012703906,0.00039867408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014747526,0.00024301698,0.00041554795,0.00030566606,0.00009841914,0.000028596909,0.00013113275,0.00014899735,0.00026113022],"category_scores_gemma":[0.0003424613,0.00019394721,0.000044793793,0.0011924981,0.000087752414,0.00015262575,0.00004942009,0.0003063331,0.00011669301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007265619,0.00080780656,0.91026276,0.0014884196,0.0005854229,0.013385314,0.02930354,0.0001056846,0.0048114774,0.00023556047,0.00831462,0.023433777],"study_design_scores_gemma":[0.004929479,0.00052744284,0.97921777,0.008367487,0.000057494693,0.00012662922,0.00034158683,0.000017762963,0.0053431722,0.000020223608,0.0008036195,0.00024736294],"about_ca_topic_score_codex":0.00012649482,"about_ca_topic_score_gemma":0.00030062022,"teacher_disagreement_score":0.068954974,"about_ca_system_score_codex":0.00020741495,"about_ca_system_score_gemma":0.00035093637,"threshold_uncertainty_score":0.7908938},"labels":[],"label_agreement":null},{"id":"W4388516135","doi":"10.1093/crocol/otad070","title":"Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ulcerative colitis; Phase (matter); Colitis; Medicine; Internal medicine; Surgery; Physics; Disease","score_opus":0.025577921023351657,"score_gpt":0.2965194893346426,"score_spread":0.27094156831129096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388516135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584484,0.00011840597,0.00001498512,0.00023762215,0.00014878936,0.0010259539,0.0024847698,0.000020320373,0.00010433062],"genre_scores_gemma":[0.9985894,0.00013845696,0.00005545601,0.0003221629,0.00009754565,0.00016030947,0.00047644283,0.000025725636,0.00013452393],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980069,0.0003125564,0.00049005856,0.0005725083,0.00024436874,0.00037362552],"domain_scores_gemma":[0.9986269,0.000086862114,0.00025723578,0.00040112852,0.00047830152,0.00014959974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027765887,0.00023787611,0.00031130915,0.000054927565,0.000155947,0.000039436047,0.00016255002,0.000113808666,0.0000035653425],"category_scores_gemma":[0.0009094252,0.00018680081,0.000051588308,0.00020014767,0.0003028252,0.000026083077,0.00019530035,0.0001313597,0.0000062398276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92373276,0.0013625899,0.016163219,0.00031430705,0.0015970693,0.0001713222,0.018217873,0.00026359575,0.0037109342,0.0006786311,0.012544303,0.02124341],"study_design_scores_gemma":[0.0069025117,0.00027943627,0.9857166,0.00009587283,0.000023151251,3.9186813e-7,0.002770533,0.00003294718,0.003356273,0.00019317614,0.00039382157,0.00023533314],"about_ca_topic_score_codex":0.0004970636,"about_ca_topic_score_gemma":0.0022552505,"teacher_disagreement_score":0.96955335,"about_ca_system_score_codex":0.00008421031,"about_ca_system_score_gemma":0.00022885938,"threshold_uncertainty_score":0.7617516},"labels":[],"label_agreement":null},{"id":"W4390640897","doi":"10.1093/crocol/otae001","title":"Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Quality of life (healthcare); Placebo; Internal medicine; Ulcerative colitis; Physical therapy; Gastroenterology; Disease","score_opus":0.02051848259193821,"score_gpt":0.2878773408196919,"score_spread":0.2673588582277537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390640897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522185,0.00043432877,0.000107874235,0.00013070286,0.00017926538,0.00083272177,0.0028294239,0.000017294486,0.0002465569],"genre_scores_gemma":[0.99869496,0.00017785927,0.00017783155,0.00009287051,0.0000869778,0.00010263662,0.00037123892,0.000031533684,0.00026410466],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978013,0.00028985093,0.00058952224,0.00058360386,0.00040890602,0.00032678575],"domain_scores_gemma":[0.99829316,0.000075107004,0.00031211067,0.00026415964,0.0008908659,0.00016457267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032645982,0.00025701264,0.00038640725,0.00010325198,0.00008680034,0.000040248142,0.0001009349,0.00013743406,0.000010654879],"category_scores_gemma":[0.00071508135,0.00022206602,0.00006038011,0.0001822724,0.00015889216,0.000041320956,0.000072681054,0.00013516643,0.0000027829203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8076158,0.0033375008,0.11683306,0.0014383243,0.008527796,0.0003584023,0.02828806,0.0009771712,0.0035632828,0.002442006,0.0097,0.016918601],"study_design_scores_gemma":[0.005564649,0.000438238,0.9850543,0.0003547023,0.00008500858,5.301037e-7,0.0011946361,0.00002813798,0.0060904967,0.00014129032,0.00075914164,0.00028885735],"about_ca_topic_score_codex":0.00034840388,"about_ca_topic_score_gemma":0.002227876,"teacher_disagreement_score":0.8682212,"about_ca_system_score_codex":0.00020051058,"about_ca_system_score_gemma":0.00043121175,"threshold_uncertainty_score":0.905559},"labels":[],"label_agreement":null},{"id":"W4391463039","doi":"10.1093/crocol/otae006","title":"Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; New South Wales Government; Crohn's and Colitis Canada; Pfizer; Alberta Children's Hospital Research Institute; Eli Lilly and Company","keywords":"Medicine; Tofacitinib; Breastfeeding; Infliximab; Pregnancy; Inflammatory bowel disease; Pediatrics; Ulcerative colitis; Vedolizumab; Vaccination; Disease; Obstetrics; Immunology; Internal medicine","score_opus":0.011582987073521902,"score_gpt":0.29568045543708943,"score_spread":0.28409746836356753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391463039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881146,0.008975721,0.0001179175,0.0008072804,0.00022173232,0.0005601055,0.000038079634,0.00010667812,0.0010578868],"genre_scores_gemma":[0.9976597,0.0013956064,0.00019300004,0.00013515171,0.000096710384,0.00011250155,0.00002619068,0.000017824588,0.00036332448],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99876696,0.000056636156,0.00033900532,0.0003216825,0.00018145498,0.00033426157],"domain_scores_gemma":[0.9994816,0.00008467736,0.000068584435,0.00015416044,0.00005681976,0.00015414113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028716357,0.00016943442,0.00028846567,0.0002158075,0.00009182915,0.0001048626,0.00005248467,0.0001260106,0.00019506861],"category_scores_gemma":[0.00009066259,0.00015628515,0.000041587402,0.00017607037,0.00006109178,0.00032215513,0.00008143387,0.0003209545,0.000008902022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074815884,0.00026058962,0.43171912,0.0017983064,0.0002686433,0.0042014155,0.008925481,0.000003600599,0.0112444125,0.0022701877,0.00015706105,0.53840303],"study_design_scores_gemma":[0.0021078163,0.00024376895,0.9915937,0.0016620037,0.00005787305,0.0013435846,0.00047410285,0.00021430496,0.0010374007,0.00014113379,0.00097073766,0.00015354429],"about_ca_topic_score_codex":0.0001606405,"about_ca_topic_score_gemma":0.000039985214,"teacher_disagreement_score":0.5598746,"about_ca_system_score_codex":0.00016479865,"about_ca_system_score_gemma":0.00014530789,"threshold_uncertainty_score":0.63731235},"labels":[],"label_agreement":null},{"id":"W4392004938","doi":"10.1093/crocol/otae009","title":"Dietary Magnesium Intake Is Inversely Associated With Ulcerative Colitis: A Case–Control Study","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Ulcerative colitis; Magnesium; Gastroenterology; Medicine; Internal medicine; Food science; Environmental health; Chemistry; Disease","score_opus":0.0231030594569894,"score_gpt":0.28683948561900935,"score_spread":0.26373642616202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392004938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775062,0.0015514514,0.000019292138,0.0025431535,0.002136426,0.003529853,0.0023324501,0.00078830676,0.009592829],"genre_scores_gemma":[0.9905228,0.0000026070566,0.000039985942,0.0058905953,0.00057093165,0.0006664167,0.000060189544,0.00010829847,0.0021381646],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9958978,0.00073300995,0.0006582888,0.0009789292,0.00059859885,0.0011333373],"domain_scores_gemma":[0.99756736,0.0005645302,0.00014433541,0.0005638159,0.00035392726,0.00080603466],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055425306,0.00051956257,0.00061195577,0.00027456263,0.0006207093,0.0004963196,0.00023279981,0.00020546623,0.0022106562],"category_scores_gemma":[0.00031447483,0.00048565582,0.00016892025,0.00080829626,0.0002439203,0.00046553917,0.000060351394,0.0005345194,0.0002937995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057477847,0.008118662,0.12917349,0.009772182,0.0017338998,0.37147948,0.10629208,0.00007821877,0.00007687368,0.002257607,0.16265696,0.15088269],"study_design_scores_gemma":[0.0067123026,0.0046132253,0.9644383,0.00024928778,0.0018734066,0.0010555161,0.009628554,0.00382249,0.00005780102,0.0010276802,0.0053642946,0.001157132],"about_ca_topic_score_codex":0.0038268247,"about_ca_topic_score_gemma":0.010707002,"teacher_disagreement_score":0.8352648,"about_ca_system_score_codex":0.0005253502,"about_ca_system_score_gemma":0.00054712844,"threshold_uncertainty_score":0.9997595},"labels":[],"label_agreement":null},{"id":"W4392886292","doi":"10.1093/crocol/otae019","title":"Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Clinical trial; Placebo; Inflammatory bowel disease; Inclusion (mineral); Family medicine; Outreach; Patient recruitment; Disease; Alternative medicine; Physical therapy; Internal medicine; Psychology; Pathology","score_opus":0.6111138710781772,"score_gpt":0.6296515015508516,"score_spread":0.018537630472674427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392886292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916814,0.000814044,0.0010837053,0.0012797258,0.0010064812,0.0038173308,0.0000924695,0.00009990676,0.00012491657],"genre_scores_gemma":[0.9973261,0.00046911184,0.0006357112,0.00044206996,0.0002372783,0.00073707884,0.000032589403,0.00006889489,0.000051207826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98634464,0.0062876744,0.0033771354,0.0010234683,0.0019895623,0.000977537],"domain_scores_gemma":[0.97771716,0.018619489,0.00037143228,0.00088109815,0.00095502066,0.0014558076],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022865541,0.00033691892,0.0012518555,0.00034773102,0.000077419485,0.00014453876,0.00026109704,0.00033357707,0.0002654034],"category_scores_gemma":[0.055065945,0.00025841588,0.00033062647,0.00075398805,0.0006439009,0.00038671005,0.00034983328,0.002077494,0.000057926838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015822662,0.007755038,0.87320733,0.0016071659,0.00047855268,0.0019418655,0.004009945,0.000049415765,0.000011749814,0.0018484375,0.00054229633,0.09272556],"study_design_scores_gemma":[0.008094875,0.003064467,0.9738611,0.0016846315,0.00081078446,0.000001242976,0.0014429609,0.00297626,0.00026710398,0.0049646804,0.0025095295,0.00032234413],"about_ca_topic_score_codex":0.000046983034,"about_ca_topic_score_gemma":0.00013346998,"teacher_disagreement_score":0.100653805,"about_ca_system_score_codex":0.00024285565,"about_ca_system_score_gemma":0.0015011122,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W4393106191","doi":"10.1093/crocol/otae015","title":"Evaluation of Factors Contributing to Diagnosis of Crohn’s Disease in the Face of Increasing Trend in Pakistan","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Diarrhea; Crohn's disease; Abdominal pain; Medical record; Inflammatory bowel disease; Radiological weapon; Health care; Retrospective cohort study; Developing country; Limited resources; Internal medicine; Pediatrics; Surgery","score_opus":0.019269306795005953,"score_gpt":0.3216546604060501,"score_spread":0.3023853536110442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393106191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997327,0.0012704848,0.000024821666,0.000045775927,0.000059335543,0.0005554885,0.00053871993,0.000004193692,0.00017412956],"genre_scores_gemma":[0.99968314,0.000025359619,0.00001401082,0.000026070387,0.000030056526,0.000097862685,0.00010334568,0.000013478478,0.0000066834623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982519,0.00047332307,0.00043951522,0.00023600308,0.0003590785,0.00024014422],"domain_scores_gemma":[0.9992549,0.00012077652,0.000100257,0.00028869548,0.00016103797,0.00007435493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00163218,0.00012111977,0.0001745707,0.00012014734,0.000025522986,0.000019799769,0.0001747331,0.00006898756,0.000030150613],"category_scores_gemma":[0.00089511566,0.000106737,0.000097335374,0.00023235587,0.000084585874,0.000007885346,0.00008034448,0.00006208397,7.740172e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013442348,0.00031624804,0.9639773,0.0005448084,0.000098627235,0.00024564486,0.0038872536,0.0014593462,0.019320589,0.0006913104,0.00021207637,0.007902575],"study_design_scores_gemma":[0.00046560582,0.00003326997,0.9832277,0.00024340862,0.00008864082,6.356317e-7,0.00085655815,0.0002998408,0.0143426005,0.00013455137,0.00020586171,0.00010130317],"about_ca_topic_score_codex":0.00042022057,"about_ca_topic_score_gemma":0.001685947,"teacher_disagreement_score":0.019250436,"about_ca_system_score_codex":0.00007275375,"about_ca_system_score_gemma":0.00032200717,"threshold_uncertainty_score":0.43526086},"labels":[],"label_agreement":null},{"id":"W4396771004","doi":"10.1093/crocol/otae031","title":"Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Legalization; Cannabis; Inflammatory bowel disease; Medicine; Disease; Psychiatry; Traditional medicine; Internal medicine; Gastroenterology","score_opus":0.006999479675122657,"score_gpt":0.2359943108272297,"score_spread":0.22899483115210703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396771004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950327,0.00057090883,0.0000059697204,0.0027340527,0.00026992033,0.00094872084,0.00016030115,0.000027364644,0.00025000962],"genre_scores_gemma":[0.9929166,0.000016128111,0.000009802355,0.00025353188,0.00004665491,0.00018120387,0.00012614376,0.00005562823,0.006394348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757934,0.00007490381,0.000493268,0.0004238133,0.0008177004,0.0006109923],"domain_scores_gemma":[0.99891716,0.00000905629,0.000053322703,0.00036930773,0.00022628717,0.00042484436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000197673,0.0002159401,0.00035206534,0.00043939668,0.000043269574,0.000074362644,0.00011849466,0.000067826964,0.00011510548],"category_scores_gemma":[0.00021478513,0.00019712077,0.00009066254,0.00078645494,0.00008213535,0.0003203146,0.000060414626,0.00029299894,0.0000025550653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073784817,0.00010193957,0.9348136,0.0007406605,0.0000426383,0.0021212164,0.0003289922,0.00015629386,0.000014050638,0.00021824108,0.059451643,0.0012728338],"study_design_scores_gemma":[0.0015845268,0.00009416379,0.95711225,0.0008722346,0.000040221556,0.0000025452946,0.00013828801,0.00052830874,0.00007068464,0.000015847882,0.039342694,0.000198241],"about_ca_topic_score_codex":0.8312737,"about_ca_topic_score_gemma":0.9472366,"teacher_disagreement_score":0.11596294,"about_ca_system_score_codex":0.0020543241,"about_ca_system_score_gemma":0.0094761625,"threshold_uncertainty_score":0.99613917},"labels":[],"label_agreement":null},{"id":"W4399670425","doi":"10.1093/crocol/otae038","title":"Differences Between the 2016 and 2022 Food and Drug Administration Guidance—Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Ulcerative colitis; Interpretation (philosophy); Medicine; Clinical trial; Medical physics; Intensive care medicine; Internal medicine; Computer science; Disease","score_opus":0.061786576523041675,"score_gpt":0.3808542807149654,"score_spread":0.31906770419192376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854296,0.0015184208,0.010744762,0.000588593,0.00007474663,0.0010521073,0.0005218031,0.000006253762,0.00006373106],"genre_scores_gemma":[0.9983626,0.00047682182,0.00044362296,0.000052731917,0.00014641722,0.00034143106,0.00006946741,0.00000915335,0.0000977493],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982568,0.0007245052,0.0005749326,0.00028611597,0.000047861122,0.000109786684],"domain_scores_gemma":[0.9986122,0.0009746846,0.00013995572,0.00013062402,0.00007795696,0.00006454364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001998018,0.00009783118,0.00024607193,0.000032791308,0.00007350496,0.00008167837,0.00006478921,0.00008881441,0.0000035646763],"category_scores_gemma":[0.0010460904,0.000076876095,0.000056253994,0.00004006148,0.00023581857,0.000012825139,0.000041859443,0.00005849633,2.4316643e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011886598,0.00027112293,0.32894862,0.0016864294,0.0012537135,0.000031558684,0.004347646,0.000012891327,0.008198641,0.06021961,0.01800934,0.56513387],"study_design_scores_gemma":[0.00056415057,0.00031400844,0.9915267,0.00008893993,0.00007229172,0.000003467802,0.00012515766,0.0005302909,0.0011311265,0.004816053,0.00073171087,0.000096057774],"about_ca_topic_score_codex":0.0000066413777,"about_ca_topic_score_gemma":0.00022252274,"teacher_disagreement_score":0.66257817,"about_ca_system_score_codex":0.0000073145607,"about_ca_system_score_gemma":0.0002213329,"threshold_uncertainty_score":0.3134916},"labels":[],"label_agreement":null},{"id":"W4403360578","doi":"10.1093/crocol/otae056","title":"Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute; Lawson Health Research Institute; Western University","funders":"Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Inflammatory bowel disease; Psychological intervention; Adjunctive treatment; Ileostomy; Intensive care medicine; Disease; General surgery; Surgery; Internal medicine; Psychiatry","score_opus":0.010823146638998781,"score_gpt":0.28515540106879184,"score_spread":0.27433225442979303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403360578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013885438,0.9860336,0.000004583936,0.00000578203,0.00016953802,0.009919666,0.0023947386,0.000025379246,0.000058138034],"genre_scores_gemma":[0.00066470105,0.9873074,0.000016503722,0.00010680399,0.00010418193,0.00740485,0.0039139735,0.00012692464,0.00035465148],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974753,0.00027551872,0.0009061279,0.0007663211,0.00020602345,0.00037067194],"domain_scores_gemma":[0.99833363,0.000024107523,0.0003633813,0.00071580143,0.00027331285,0.00028976862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018922187,0.0005834728,0.0012687815,0.0001669329,0.00008203746,0.00007841714,0.00027027394,0.00020657311,0.000010257385],"category_scores_gemma":[0.00020704043,0.00045810774,0.000785291,0.000105269064,0.00012680615,0.00001064685,0.0002342781,0.00019735006,0.000026864978],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001582243,0.000057058358,0.00015533507,0.9959996,0.00029775122,0.00018284019,0.000039912222,1.6648829e-7,1.0238142e-8,0.00007989962,0.00087065785,0.0021585603],"study_design_scores_gemma":[0.0008291811,0.00016974716,0.00952882,0.90449595,0.008947296,0.0000075796597,0.0000357855,8.231688e-7,5.690501e-8,0.00001328604,0.075310774,0.0006606711],"about_ca_topic_score_codex":0.0000018146335,"about_ca_topic_score_gemma":0.00008455924,"teacher_disagreement_score":0.091503605,"about_ca_system_score_codex":0.0002133593,"about_ca_system_score_gemma":0.0007684523,"threshold_uncertainty_score":0.9997871},"labels":[],"label_agreement":null},{"id":"W4404614292","doi":"10.1093/crocol/otae052","title":"Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Infliximab; Inflammatory bowel disease; Medicine; Maintenance therapy; Internal medicine; Disease; Intensive care medicine; Chemotherapy","score_opus":0.00875503567726365,"score_gpt":0.24893237758128067,"score_spread":0.24017734190401702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404614292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430823,0.0008467815,0.0019189996,0.00009490314,0.00038163923,0.001240688,0.0006672322,0.000073674535,0.0004678776],"genre_scores_gemma":[0.99604946,0.00017095171,0.0001716587,0.0004897053,0.00015557586,0.00091406994,0.00024188202,0.00007733384,0.0017293519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982452,0.00006267606,0.00037862768,0.00060381,0.00019493564,0.0005147644],"domain_scores_gemma":[0.9990459,0.000034287707,0.00006885479,0.00044431593,0.00017637704,0.00023026587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018538788,0.0002877607,0.00018207404,0.000103908984,0.000091928465,0.00010920794,0.00025679104,0.0001495085,0.000012560499],"category_scores_gemma":[0.00025952497,0.00028031142,0.00021341848,0.000065148604,0.00012253378,0.000030028104,0.000115469426,0.00012640396,0.000014780283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006081234,0.0005018907,0.9643714,0.00066181325,0.00028703906,0.00047880007,0.0010747783,0.005428808,0.0011796954,0.0024423683,0.010774703,0.006717468],"study_design_scores_gemma":[0.001827921,0.00007263933,0.9591752,0.00013431616,0.000020139087,7.163796e-7,0.000028314702,0.032219768,0.00017434165,0.0013018195,0.004695094,0.00034972015],"about_ca_topic_score_codex":0.0000052793444,"about_ca_topic_score_gemma":0.00006172021,"teacher_disagreement_score":0.026790962,"about_ca_system_score_codex":0.000116381685,"about_ca_system_score_gemma":0.00046177531,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W4404985157","doi":"10.1093/crocol/otae071","title":"Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn’s Disease Patients","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"McGill University Health Centre; McGill University","keywords":"Ustekinumab; Medicine; Internal medicine; Gastroenterology; Crohn's disease; Disease; Infliximab","score_opus":0.007755674367782097,"score_gpt":0.24286549455495035,"score_spread":0.23510982018716825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404985157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960471,0.00029151357,0.00012858477,0.00029385125,0.00024184656,0.0007659215,0.0019871332,0.000042457606,0.00020158284],"genre_scores_gemma":[0.9975904,0.000046822115,0.000022571916,0.00024071007,0.00023159874,0.00017704717,0.00041310384,0.000035642966,0.0012420964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983978,0.0001556089,0.00023442529,0.00055625546,0.00023027626,0.00042559276],"domain_scores_gemma":[0.99894196,0.000035451205,0.000057494566,0.0002952624,0.000110989735,0.000558864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011025414,0.000219822,0.00016420416,0.000076420925,0.00014064877,0.00021585115,0.00011806919,0.00012254009,0.000048805694],"category_scores_gemma":[0.00022982621,0.00025231307,0.00007831643,0.000123687,0.00004709904,0.00003685177,0.00013141191,0.0001315348,0.000038987982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007528122,0.00010593364,0.99430925,0.0002081946,0.00008485828,0.0003905726,0.00010003233,0.00014657724,0.00021920257,0.00015739504,0.0017326034,0.0017925523],"study_design_scores_gemma":[0.0008701356,0.000030369843,0.9949515,0.00008928408,0.00009138126,2.1796515e-7,0.000009468578,0.00044281027,0.00023886625,0.00021200233,0.0028104652,0.0002534834],"about_ca_topic_score_codex":0.000033587618,"about_ca_topic_score_gemma":0.00019336081,"teacher_disagreement_score":0.0015740294,"about_ca_system_score_codex":0.00023456551,"about_ca_system_score_gemma":0.0004704129,"threshold_uncertainty_score":0.9999929},"labels":[],"label_agreement":null},{"id":"W4405670959","doi":"10.1093/crocol/otae073","title":"Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Chugai Pharmaceutical; Bristol-Myers Squibb Canada; Genentech; LEO Pharma; Australian Renewable Energy Agency; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Amgen; Boehringer Ingelheim; AbbVie; Novartis; Pfizer","keywords":"Work productivity; Inflammatory bowel disease; Productivity; Disease; Work (physics); Health care; Resource (disambiguation); Medicine; Business; Physical therapy; Intensive care medicine; Internal medicine; Engineering; Economics; Computer science; Economic growth; Mechanical engineering","score_opus":0.020744899378130933,"score_gpt":0.3042277678905848,"score_spread":0.28348286851245386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405670959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975149,0.0011424824,0.000029204597,0.00016776873,0.00009358198,0.0006474988,0.00017334857,0.000034971792,0.00019622632],"genre_scores_gemma":[0.9993075,0.00008022614,0.00000834127,0.000040808634,0.00016701513,0.000082081315,0.00010359783,0.00003835822,0.00017207659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998526,0.0002154418,0.00023080743,0.000533486,0.00017684641,0.00031743734],"domain_scores_gemma":[0.99913484,0.000021206606,0.000076421835,0.00045444758,0.00006385546,0.00024925862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024386782,0.00021726043,0.0001513574,0.00013444548,0.00006308808,0.000060558617,0.000108141816,0.00012209636,0.000015294701],"category_scores_gemma":[0.00013318865,0.00021718451,0.00011912517,0.00016709903,0.00014668888,0.000018837323,0.000116408744,0.00014522774,0.0000039268807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064299502,0.0004932659,0.9659573,0.0015498293,0.00011817374,0.0006881547,0.0004741826,0.0006168054,0.0049676853,0.0006774891,0.0028332,0.015193999],"study_design_scores_gemma":[0.0003583329,0.00019790087,0.9965462,0.00027011638,0.000016204574,0.0000036767751,0.00001899032,0.0001412507,0.0011874593,0.00012986969,0.00093113363,0.00019885959],"about_ca_topic_score_codex":0.000057608686,"about_ca_topic_score_gemma":0.000111799025,"teacher_disagreement_score":0.03058894,"about_ca_system_score_codex":0.00011741585,"about_ca_system_score_gemma":0.00047522562,"threshold_uncertainty_score":0.8856527},"labels":[],"label_agreement":null},{"id":"W4406812509","doi":"10.1093/crocol/otae083","title":"Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"UCB Pharma","keywords":"Medicine; Certolizumab pegol; Internal medicine; Odds ratio; Observational study; Incidence (geometry); Confidence interval; Adverse effect; Concomitant; Disease","score_opus":0.015008381614886235,"score_gpt":0.24938624551259436,"score_spread":0.23437786389770812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406812509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881481,0.0019145485,0.000046112258,0.0004895246,0.0002320679,0.0007001013,0.0077430713,0.00003676678,0.00068974396],"genre_scores_gemma":[0.9901569,0.0001217665,0.0000485308,0.00013790613,0.0003988127,0.00010808618,0.0076834927,0.00004826121,0.0012962656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982543,0.00011670311,0.00025063232,0.0007670644,0.00023745275,0.00037385675],"domain_scores_gemma":[0.99805015,0.000031503907,0.000056136603,0.0016072999,0.00006038249,0.00019449597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004021968,0.000279517,0.00015935962,0.000025900734,0.00013533376,0.00014848312,0.0005741333,0.00011426538,0.00020300444],"category_scores_gemma":[0.0000611461,0.00019807788,0.00007987159,0.000092609,0.0001626344,0.00001827204,0.00028448095,0.00012960019,0.000063982836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034904934,0.0015179715,0.7807966,0.000421084,0.0010878935,0.04319506,0.00088874984,0.000114221475,0.00014288869,0.0013505622,0.11112545,0.024454597],"study_design_scores_gemma":[0.0014287597,0.000067313624,0.87816536,0.000109112625,0.000096221695,0.000009187204,0.00003988875,0.00013321471,0.000025776208,0.00007575646,0.119608365,0.00024105582],"about_ca_topic_score_codex":0.00025849044,"about_ca_topic_score_gemma":0.0016740151,"teacher_disagreement_score":0.09736876,"about_ca_system_score_codex":0.00013295539,"about_ca_system_score_gemma":0.0007033848,"threshold_uncertainty_score":0.8077381},"labels":[],"label_agreement":null},{"id":"W4407272523","doi":"10.1093/crocol/otaf009","title":"Multimodal Lifestyle Intervention Improves Fatigue in Quiescent Inflammatory Bowel Disease: A Controlled Study","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Maag Lever Darm Stichting; McMaster University; University of Pittsburgh","keywords":"Inflammatory bowel disease; Intervention (counseling); Medicine; Physical therapy; Disease; Internal medicine; Gastroenterology; Psychiatry","score_opus":0.007394069688567413,"score_gpt":0.26939630727070774,"score_spread":0.2620022375821403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407272523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456835,0.0022154632,0.00012219834,0.00005921719,0.0006334374,0.0019371108,0.00008217406,0.0000885126,0.00029351367],"genre_scores_gemma":[0.9971277,0.000050185165,0.000020865655,0.0000992167,0.00039359042,0.0009000568,0.0001319864,0.000058014808,0.0012183724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777204,0.00029043466,0.0005923982,0.0006500004,0.00024924485,0.00044589723],"domain_scores_gemma":[0.99901056,0.000026700644,0.00008886408,0.0005080833,0.000092812836,0.00027295627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042966544,0.00030669893,0.00026310896,0.00015509181,0.00008622175,0.00018544342,0.00025400287,0.00013140473,0.00007373023],"category_scores_gemma":[0.0002526092,0.00030827025,0.00030840226,0.00009569782,0.00011246094,0.000022921575,0.00020607178,0.00018138427,0.000060130955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049949527,0.008095076,0.7903404,0.0042713084,0.002277222,0.027248427,0.003890616,0.00095297233,0.06657515,0.0029978673,0.011530312,0.031871133],"study_design_scores_gemma":[0.0067842924,0.0001935058,0.9860346,0.0002121118,0.00009343356,0.000004602047,0.0004223706,0.002381314,0.00053334906,0.000082613195,0.0028774578,0.00038040098],"about_ca_topic_score_codex":0.00007171679,"about_ca_topic_score_gemma":0.0007025864,"teacher_disagreement_score":0.19569415,"about_ca_system_score_codex":0.00010030128,"about_ca_system_score_gemma":0.00031582962,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W4407593379","doi":"10.1093/crocol/otaf013","title":"Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study)","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Manitoba; University of Alberta Hospital; Alberta Hospital Edmonton; Health Sciences Centre; McMaster University Medical Centre","funders":"Pfizer Canada; Pfizer","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Intensive care medicine; Internal medicine; Disease","score_opus":0.008899398249892844,"score_gpt":0.2713860190936181,"score_spread":0.26248662084372526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407593379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562896,0.00029565074,0.00064594473,0.00029259175,0.0007019433,0.0035099597,0.0012170341,0.00009052634,0.0076173986],"genre_scores_gemma":[0.97765064,0.00009400266,0.0002163383,0.0005651588,0.00043659104,0.0020832964,0.00038127828,0.000066321496,0.01850639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982071,0.00013617867,0.0003218885,0.0006375036,0.00021683732,0.00048050738],"domain_scores_gemma":[0.99905086,0.000028924103,0.000058448957,0.000569226,0.00014960312,0.00014295778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026901142,0.00028656237,0.00020705495,0.00005470923,0.00027610315,0.00025397952,0.00034472175,0.00011515743,0.00017871665],"category_scores_gemma":[0.000035586443,0.0002472434,0.00026236777,0.00013111765,0.0001367139,0.000012382344,0.00020100124,0.00009797561,0.000084491985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028991321,0.002372072,0.008135626,0.0029452674,0.019174144,0.023217428,0.00910783,0.00014658281,0.0036038184,0.10154569,0.71640396,0.08435623],"study_design_scores_gemma":[0.004033518,0.00055727136,0.476956,0.00007780098,0.00065699284,0.000059446884,0.0012652525,0.00013273893,0.0015829966,0.0013782859,0.5125886,0.0007110467],"about_ca_topic_score_codex":0.000012396194,"about_ca_topic_score_gemma":0.000084094536,"teacher_disagreement_score":0.46882036,"about_ca_system_score_codex":0.00006546503,"about_ca_system_score_gemma":0.00014706915,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W4408142360","doi":"10.1093/crocol/otaf016","title":"Research Participation in Inflammatory Bowel Disease Studies: What Do Patients Want?","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Takeda Canada; Pfizer","keywords":"Inflammatory bowel disease; Medicine; Inflammatory Bowel Diseases; Gastroenterology; Internal medicine; Disease","score_opus":0.24426163921130473,"score_gpt":0.5295187038307297,"score_spread":0.285257064619425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408142360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985926,0.0041527795,0.0000035770945,0.0008472864,0.0025767141,0.0032079227,0.00005277777,0.00004996403,0.0031829942],"genre_scores_gemma":[0.9885192,0.0028245265,0.000015187271,0.0029066973,0.00013716167,0.0028216424,0.00019100928,0.000018985933,0.0025655902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530995,0.0013876865,0.001017781,0.00044917484,0.0006391971,0.001196212],"domain_scores_gemma":[0.99731797,0.0009567862,0.00015285508,0.00049004547,0.0006407878,0.00044157804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019096714,0.0001787116,0.00026736336,0.0004051823,0.0011829641,0.000049024813,0.00021736199,0.0001420431,0.00025238408],"category_scores_gemma":[0.0004042182,0.00017076521,0.00004843405,0.0005184228,0.00016259785,0.00043019385,0.00033699835,0.0006789068,0.00055416115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087931176,0.00045379222,0.95373756,0.004174721,0.000020372472,0.00002674671,0.009638456,0.0000067331025,0.0000010378695,0.00621541,0.012735468,0.012110421],"study_design_scores_gemma":[0.0018942218,0.00012051993,0.9311364,0.006882622,0.000011834392,1.08947e-8,0.018083362,0.00006193688,0.000010594221,0.006333106,0.035324454,0.00014088074],"about_ca_topic_score_codex":0.00029654437,"about_ca_topic_score_gemma":0.0011233459,"teacher_disagreement_score":0.022601074,"about_ca_system_score_codex":0.0013208502,"about_ca_system_score_gemma":0.000974884,"threshold_uncertainty_score":0.9098523},"labels":[],"label_agreement":null},{"id":"W4408497622","doi":"10.1093/crocol/otaf021","title":"Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease Patients","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vedolizumab; Adalimumab; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Ustekinumab; Golimumab; Odds ratio; Infliximab; Pouchitis; Crohn's disease; Disease","score_opus":0.006301511030507384,"score_gpt":0.25685807383485415,"score_spread":0.2505565628043468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408497622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981627,0.00051613484,0.000051496583,0.00018467674,0.00012104719,0.00044561262,0.00022870552,0.000009288287,0.00028036736],"genre_scores_gemma":[0.9987858,0.00013467835,0.000014965761,0.00028986737,0.000023089853,0.00015882388,0.0003027268,0.000011764418,0.00027826792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892426,0.0000945365,0.00036433488,0.00027469464,0.00013840734,0.00020375912],"domain_scores_gemma":[0.99929845,0.000021089149,0.00007857923,0.00029530504,0.0000930678,0.00021347956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010028998,0.00013753831,0.00013883064,0.00015948819,0.00005257553,0.00002146332,0.00013047749,0.00007808051,0.000014024126],"category_scores_gemma":[0.0006346397,0.00015246612,0.000052313288,0.00009422183,0.0002190079,0.00001518854,0.0001310524,0.000059721497,0.0000015277875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005159816,0.00019196376,0.9946711,0.00021392538,0.000015917934,0.000036556972,0.00006128662,0.00002456556,0.00003980128,0.0034552964,0.0002633392,0.00051023945],"study_design_scores_gemma":[0.0011675076,0.000010859952,0.9964474,0.000089822526,0.000028393384,4.844556e-8,0.000029626915,0.00012484918,0.000054085285,0.0012547352,0.0006629565,0.00012971493],"about_ca_topic_score_codex":0.000034102468,"about_ca_topic_score_gemma":0.00044771345,"teacher_disagreement_score":0.0022005613,"about_ca_system_score_codex":0.000034699646,"about_ca_system_score_gemma":0.00044309138,"threshold_uncertainty_score":0.6217388},"labels":[],"label_agreement":null},{"id":"W4408547160","doi":"10.1093/crocol/otaf011","title":"US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn’s Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Quality of life (healthcare); Disease; Crohn's disease; Health care; Health professionals; Physical therapy; Family medicine; Internal medicine; Nursing","score_opus":0.013257514185753055,"score_gpt":0.2842826005898391,"score_spread":0.27102508640408607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408547160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468655,0.012502381,0.0000013180992,0.000398978,0.00005668377,0.0006560211,0.0013285145,0.000008449168,0.00036112932],"genre_scores_gemma":[0.99774384,0.001299351,0.00003191668,0.0004607454,0.000034504137,0.000093708106,0.0002782764,0.000015351676,0.000042278316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977358,0.0011276505,0.00033594418,0.00043711314,0.0001408532,0.0002226484],"domain_scores_gemma":[0.99883634,0.00017670491,0.00019845885,0.00041232436,0.00013643122,0.00023972044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003538468,0.00020937854,0.00018546509,0.000061601444,0.00037929355,0.00008380591,0.00015383385,0.00005457116,0.0000018658657],"category_scores_gemma":[0.00052063353,0.00017410885,0.000028348026,0.00007142777,0.0007376229,0.00001584613,0.0004100315,0.0001550967,9.1816034e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010135027,0.0001567819,0.8571633,0.00032895897,0.000089171146,0.00018260567,0.12269869,0.000013234712,0.00012442157,0.001718198,0.0016783777,0.0057112575],"study_design_scores_gemma":[0.0010484299,0.00006762175,0.9513162,0.0003967965,0.000012159167,8.2080015e-7,0.046650197,0.000014907754,0.00006984638,0.00004249156,0.00022195849,0.00015860447],"about_ca_topic_score_codex":0.00063540693,"about_ca_topic_score_gemma":0.003957474,"teacher_disagreement_score":0.09415288,"about_ca_system_score_codex":0.00003813734,"about_ca_system_score_gemma":0.00033516056,"threshold_uncertainty_score":0.70999527},"labels":[],"label_agreement":null},{"id":"W4409689439","doi":"10.1093/crocol/otaf029","title":"Pregnant Pause? Not for IBD Care—A Single Tertiary Care Center Prospective Cohort Study Affirming IBD Management in Pregnancy","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"Tertiary care; Medicine; Pregnancy; Prospective cohort study; Obstetrics; Cohort study; Cohort; Family medicine; Internal medicine","score_opus":0.015027364276208313,"score_gpt":0.303788734187027,"score_spread":0.2887613699108187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90316,0.014769283,0.0011939732,0.0009259949,0.001600974,0.0306678,0.000246077,0.00037984102,0.047056053],"genre_scores_gemma":[0.9899406,0.0001964903,0.00044546212,0.00047961698,0.000112483525,0.0044011315,0.00013510602,0.000045756744,0.004243384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974327,0.00008297764,0.00061051955,0.0007887004,0.00040394458,0.00068116235],"domain_scores_gemma":[0.9985545,0.00008254791,0.00013605223,0.00075379125,0.00027910646,0.00019399068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016085674,0.00033171655,0.0005510769,0.00033993306,0.0001890641,0.0000543731,0.00023762797,0.00013575639,0.00004244703],"category_scores_gemma":[0.00015093535,0.00031126116,0.00015093814,0.00036438266,0.000099726676,0.00016757392,0.00017069909,0.00024652245,0.000013812996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069543236,0.0017850922,0.89176846,0.0027368108,0.0005397818,0.00062315125,0.018705184,0.0000037461364,0.000119107535,0.00046157438,0.0012785477,0.0812831],"study_design_scores_gemma":[0.0076515605,0.0004886387,0.9602262,0.011599858,0.00044588777,0.000013782095,0.011359693,0.0000136711105,0.0022441337,0.00007641826,0.0056025595,0.00027760773],"about_ca_topic_score_codex":0.00014247005,"about_ca_topic_score_gemma":0.0003695222,"teacher_disagreement_score":0.08678056,"about_ca_system_score_codex":0.00094127853,"about_ca_system_score_gemma":0.00027472575,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W4410105772","doi":"10.1093/crocol/otaf024","title":"Global Patterns of <i>Clostridioides difficile</i> Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors","year":2025,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Odds ratio; Internal medicine; Meta-analysis; Inflammatory bowel disease; Population; Epidemiology; Disease; Environmental health","score_opus":0.03648110628675085,"score_gpt":0.3361699554526039,"score_spread":0.2996888491658531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410105772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119553074,0.86739254,0.000006437134,0.000013499662,0.000021588294,0.005519228,0.0074490556,0.00002051959,0.000024050489],"genre_scores_gemma":[0.014490927,0.9841313,0.000008161156,0.00002908495,0.000011449974,0.0005986453,0.00055949384,0.00003120957,0.00013974965],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936792,0.0016431111,0.0026629474,0.0008977114,0.0005953618,0.0005216706],"domain_scores_gemma":[0.9946509,0.001661492,0.0018027553,0.0010521514,0.00045271125,0.0003800101],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012288619,0.0007610466,0.011274564,0.0008711849,0.000069908405,0.000018782857,0.00022049819,0.00034427256,0.00008825367],"category_scores_gemma":[0.0031508766,0.00049749116,0.0017265526,0.0017134679,0.00033868977,0.00008034305,0.00025569112,0.0004799771,9.982862e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006817885,0.0001905893,0.32033613,0.6423134,0.036505256,0.000011814616,0.000008717858,0.000002033297,5.1325757e-9,0.000021751357,0.000024982939,0.0005170957],"study_design_scores_gemma":[0.00037592495,0.0001670443,0.3504423,0.103668414,0.5448341,0.000003132272,0.0000056078015,0.000003288851,4.4645364e-7,0.0000027362498,0.0002600707,0.00023695905],"about_ca_topic_score_codex":0.0008968621,"about_ca_topic_score_gemma":0.0002926145,"teacher_disagreement_score":0.538645,"about_ca_system_score_codex":0.00032535422,"about_ca_system_score_gemma":0.0006226036,"threshold_uncertainty_score":0.9997477},"labels":[],"label_agreement":null},{"id":"W4410314435","doi":"10.1093/crocol/otaf035","title":"The Spectrum of Psychiatric Comorbidity in Individuals With Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Manitoba; Manitoba Health; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Pfizer Foundation; Arthritis Society; Crohn's and Colitis Canada; Multiple Sclerosis Society; Dalhousie University; Biogen; Pfizer; U.S. Department of Defense","keywords":"Psychiatric comorbidity; Comorbidity; Inflammatory bowel disease; Medicine; Psychiatry; Psychiatric Disease; Disease; Internal medicine","score_opus":0.0041875881414529395,"score_gpt":0.23076089782543413,"score_spread":0.22657330968398118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410314435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944694,0.0012656881,0.000045456425,0.00034624868,0.00019704395,0.00049768825,0.00010036418,0.000015141746,0.0030629702],"genre_scores_gemma":[0.998421,0.00024679964,0.000051984374,0.00024133723,0.00010063348,0.000103679755,0.00004628439,0.000018958892,0.00076932105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865204,0.00014015714,0.00034141017,0.0003225342,0.00018719421,0.00035666264],"domain_scores_gemma":[0.9989539,0.000029202096,0.00012966555,0.00067863154,0.000073463074,0.00013514279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002773091,0.00018305951,0.00014072782,0.00009848778,0.00015375111,0.000042169573,0.00038208862,0.0000940443,0.000018387072],"category_scores_gemma":[0.00010036001,0.00014841865,0.00009316432,0.00019335384,0.0003045826,0.0000066948155,0.00015722413,0.00012760577,0.000008281755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010749415,0.00012241598,0.98562324,0.00015339651,0.00007821447,0.00012735257,0.000034413904,0.00008504137,0.00022183746,0.007226105,0.0048312894,0.0004217305],"study_design_scores_gemma":[0.0009592098,0.000039432514,0.97168297,0.000044315584,0.000038440743,0.000001863251,0.00004823049,0.000019637817,0.00084522174,0.0014474185,0.024709305,0.00016395049],"about_ca_topic_score_codex":0.000024494742,"about_ca_topic_score_gemma":0.00075055525,"teacher_disagreement_score":0.019878017,"about_ca_system_score_codex":0.000033848093,"about_ca_system_score_gemma":0.0006991637,"threshold_uncertainty_score":0.60523367},"labels":[],"label_agreement":null},{"id":"W4411272591","doi":"10.1093/crocol/otaf043","title":"Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Calprotectin; Ulcerative colitis; Gastroenterology; Feces; Medicine; Internal medicine; C-reactive protein; Colitis; Inflammatory bowel disease; Inflammation; Biology; Disease; Microbiology","score_opus":0.002991924052892428,"score_gpt":0.2035348890735019,"score_spread":0.20054296502060948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411272591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968436,0.00007970688,0.00003626979,0.00006893984,0.000026268734,0.0015865467,0.00009631282,0.000018571855,0.001243818],"genre_scores_gemma":[0.99802387,0.000006365007,0.00017184,0.00011665818,0.000018582785,0.0004886566,0.00008555835,0.000017355602,0.0010711076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864703,0.0002195934,0.00019101048,0.00048012845,0.00014103048,0.0003212313],"domain_scores_gemma":[0.9993672,0.000026091682,0.00013462793,0.00017673887,0.00020121598,0.00009417306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011034564,0.00022118563,0.00022286517,0.00008361827,0.00012964156,0.0000515979,0.00006523902,0.00019147401,0.000011700221],"category_scores_gemma":[0.00017500487,0.00019561924,0.000020484606,0.00012291483,0.00016310878,0.00001571246,0.000068380206,0.00017040638,0.000001908566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00827363,0.00021315739,0.98629296,0.00013095603,0.00016570381,0.00028159405,0.00023186956,0.0000028307531,0.0019452078,0.00037321678,0.00015604265,0.0019328028],"study_design_scores_gemma":[0.0035966653,0.0003844037,0.98444605,0.00012893286,0.000034226046,0.0000033642086,0.000076006574,0.000009415012,0.010512208,0.00008369535,0.0005303433,0.00019468252],"about_ca_topic_score_codex":0.00029210752,"about_ca_topic_score_gemma":0.0036397243,"teacher_disagreement_score":0.008567,"about_ca_system_score_codex":0.00026818694,"about_ca_system_score_gemma":0.00021978012,"threshold_uncertainty_score":0.79771215},"labels":[],"label_agreement":null},{"id":"W4412124270","doi":"10.1093/crocol/otaf031","title":"Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naïve Patients With Early or Late Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"Takeda Foundation","keywords":"Vedolizumab; Ustekinumab; Crohn's disease; Medicine; Disease; Dermatology; Internal medicine; Adalimumab","score_opus":0.011623848038346542,"score_gpt":0.28653118877797956,"score_spread":0.274907340739633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412124270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722004,0.00017746942,0.000008725157,0.000024358267,0.000121479454,0.0015715619,0.00070966705,0.000012067192,0.00015464688],"genre_scores_gemma":[0.9992768,0.00016057222,0.00003075191,0.00006461758,0.000048267208,0.00008865966,0.00016893333,0.000017322545,0.00014406389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976624,0.00076190697,0.00052756595,0.0006533568,0.00014426514,0.00025049306],"domain_scores_gemma":[0.99854994,0.00035741914,0.00020852085,0.0005860305,0.00017077761,0.00012731228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004815155,0.00022747248,0.00033406192,0.000055608012,0.00012484282,0.000038676717,0.00019051884,0.00012519877,0.000005496197],"category_scores_gemma":[0.0005492711,0.0001496953,0.000057464655,0.00015609647,0.0003593828,0.000011448703,0.00030385982,0.00014508133,0.0000010184259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06473343,0.00036448878,0.930624,0.000046038163,0.00011392235,0.00022715257,0.00016399384,0.00001038081,0.000059433973,0.000032980748,0.00007381736,0.003550376],"study_design_scores_gemma":[0.0091900425,0.00045589422,0.98934317,0.00025243472,0.00009695932,2.3380964e-7,0.00012356011,0.000016106902,0.00007076251,0.000093783005,0.00017362637,0.0001834587],"about_ca_topic_score_codex":0.00076612644,"about_ca_topic_score_gemma":0.0031735273,"teacher_disagreement_score":0.05871916,"about_ca_system_score_codex":0.000038682203,"about_ca_system_score_gemma":0.000266956,"threshold_uncertainty_score":0.6104397},"labels":[],"label_agreement":null}]}